Panichelli, C., Albert, A., Donneau, A.-F., D'Amore, S., Triffaux, J.-M., & Ansseau, M. (2018). Humor Associated with Positive Outcomes in Individual Psychotherapy. American Journal of Psychotherapy, APT-2018-0021. doi:10.1176/appi.psychotherapy.20180021 Peer Reviewed verified by ORBi |
Hanssens, L., Lustygier, V., ANSSEAU, M., Thiebaut, I., & Thimpont, J. (2017). La semaine motivationnelle : Une nouvelle approche dans le sevrage tabagique. Revue des Maladies Respiratoires, 34 (3), 188-193. doi:10.1016/j.rmr.2016.06.006 Peer Reviewed verified by ORBi |
Ansseau, M., Scantamburlo, G., & PITCHOT, W. (2017). Antidépresseurs. In J. Guelfi & F. Rouillon, Manuel de Psychiatrie (pp. 603-614). Issy-les-Moulineaux, France: Elsevier Masson. Peer reviewed |
Demaret, I., Quertemont, E., Litran, G., Magoga, C., Deblire, C., DUBOIS, N., Charlier, C., Lemaître, A., & ANSSEAU, M. (June 2016). Loss of treatment benefit when heroin-assisted treatment is stopped after 12 month. Journal of Substance Abuse Treatment, 69, 72-75. doi:10.1016/j.jsat.2016.06.005 Peer Reviewed verified by ORBi |
Scantamburlo, G., Vierset, V., Bonnet, P., Verpoorten, D., Delfosse, C., & Ansseau, M. (April 2016). VIGNETTE DIAGNOSTIQUE DE L'ETUDIANT. LogBook Numérique : Un carnet de bord réflexif comme outil d'apprentissage en contexte de stage. Revue Médicale de Liège, 71 (4), 210-215. Peer reviewed |
HITABATUMA, H., & ANSSEAU, M. (2016). Hypnose et psychiatrie: actualités et imagerie [Poster presentation]. 14ème Congrès de L'ENCEPHALE, Paris, France. |
Vanmeerbeek, M., Remmen, R., Godderis, L., Van Casteren, V., Lambrechts, M.-C., Mairiaux, P., Lemaître, A., ANSSEAU, M., Peremans, L., Dom, G., Ketterer, F., Pirenne, D., Demaret, I., Boffin, N., Antoine, J., Van Royen, K., & Symons, L. (2015). “Up To Date” Use of psychoactive substances in adults: Prevention and Treatment by general practitioners and Occupational physicians; DATa retriEval. (DR/00/60). Bruxelles, Belgium: Belspo. https://orbi.uliege.be/handle/2268/186669 |
Demaret, I., Quertemont, E., Litran, G., Magoga, C., Deblire, C., DUBOIS, N., De Roubaix, J., Charlier, C., Lemaître, A., & Ansseau, M. (01 April 2015). Efficacy of heroin-assisted treatment in Belgium: a randomised controlled trial. European Addiction Research, 21 (4), 179-187. doi:10.1159/000369337 Peer Reviewed verified by ORBi |
Lemaire, B., Geron, D., MALAISE, O., Krzesinski, J.-M., Ansseau, M., & Scantamburlo, G. (April 2015). La dépression est une complication fréquente du lupus érythémateux disséminé : considérations épidémiologiques, pathogéniques et thérapeutiques. Revue Médicale de Liège, 70 (4), 215-218. Peer reviewed |
Ledent, M., Beauvois, V., Demaret, I., ANSSEAU, M., & SCANTAMBURLO, G. (April 2015). Champs électriques et magnétiques et santé : quel message au grand public ? Revue Médicale de Liège, 70 (4), 172-178. Peer reviewed |
Demyttenaere, K., Donneau, A.-F., Albert, A., ANSSEAU, M., Constant, E., & van Heeringen, K. (March 2015). What is important in being cured from: Does discordance between physicians and patients matter? (2). Journal of Affective Disorders, 174 (2015), 372 - 377. doi:10.1016/j.jad.2014.12.002 Peer Reviewed verified by ORBi |
Demyttenaere, K., Donneau, A.-F., Albert, A., ANSSEAU, M., Constant, E., & vanHeeringen, K. (March 2015). What is important in being cured from depression? Discordance between physicians and patients (1). Journal of Affective Disorders, 174 (2015), 390-396. doi:10.1016/j.jad.2014.12.004 Peer Reviewed verified by ORBi |
DUBOIS, N., HALLET, C., SEIDEL, L., Demaret, I., LUPPENS, D., ANSSEAU, M., Rozet, E., Albert, A., Hubert, P., & Charlier, C. (2015). Estimation of the Time Interval between the Administration of Heroin and the Sampling of Blood in Chronic Inhalers. Journal of Analytical Toxicology. doi:10.1093/jat/bkv001 Peer Reviewed verified by ORBi |
Scantamburlo, G., Vierset, V., Bonnet, P., Verpoorten, D., Delfosse, C., & Ansseau, M. (2015). eLogBook,un outil d'apprentissage en contexte de stage [Paper presentation]. Congrès de l'Encéphale. |
Scantamburlo, G., Hansenne, M., Geenen, V., Legros, J.-J., & Ansseau, M. (January 2015). Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial. European Psychiatry, 30 (1), 65-68. doi:10.1016/j.eurpsy.2014.08.007 Peer Reviewed verified by ORBi |
LUPPENS, D., PIETTE, C., RADERMECKER, R., SCANTAMBURLO, G., ANSSEAU, M., & PITCHOT, W. (November 2014). Dépression et diabète de type 2. Analyse étiopathogènique d'une comorbidité fréquente. Revue Médicale de Liège, 69 (11), 611-617. Peer reviewed |
ANSSEAU, M., & Demaret, I. (04 May 2014). Heroin-assisted treatment showed better efficacy than methadone [Poster presentation]. 167th American Psychiatric Association Annual Meeting, New-York, United States. |
Lemaître, A., ANSSEAU, M., & Demaret, I. (2014). Projet TADAM: Conclusions scientifiques et recommandations. Lettre du RESPADD, (18), 2-4. |
Demaret, I., Litran, G., Magoga, C., Deblire, C., Dupont, A., De Roubaix, J., Lemaître, A., & ANSSEAU, M. (22 March 2014). Why do heroin users refuse to participate in a heroin-assisted treatment trial? Heroin Addiction and Related Clinical Problems, Epub ahead of print, March 22, 2014. Peer reviewed |
RAMAEKERS, V., Thony, B., Sequeira, J. M., Ansseau, M., Philippe, P., BOEMER, F., Bours, V., & Quadros, E. V. (2014). Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies. Molecular Genetics and Metabolism, 113 (4), 307-14. doi:10.1016/j.ymgme.2014.10.002 Peer Reviewed verified by ORBi |
ESCH, P., BOCQUET, V., PULL, C., DEMONGEOT, C., LEHNERT, T., GRAAS, M., FOND-HARMANT, L., & Ansseau, M. (2014). Santé mentale et éducation au Luxembourg: Etude des facteurs de risque psychosociaux associés au décrochage scolaire. In Prévention et promotion de la santé mentale: Une alliance transfrontalière innovante (pp. 20-41). L'Harmattan. Peer reviewed |
SCHENA, A., Ansseau, M., TRIFFAUX, J.-M., Salmon, E., WITHOFS, N., & Scantamburlo, G. (2014). Le cas clinique du mois : Pseudo-démence dépressive. Revue Médicale de Liège, 69 (2), 64-67. Peer reviewed |
Esch, P., Bocquet, V., Pull, C., Couffignal, S., Lehnert, T., Graas, M., Fond-Harmant, L., & ANSSEAU, M. (2014). The downward spiral of mental disorders and educational attainment: A systematic review on early school leaving. BMC Psychiatry, 14 (1). doi:10.1186/s12888-014-0237-4 Peer Reviewed verified by ORBi |
Ansseau, M. (2014). Heroin-assisted Tx superior to methadone for heroin addiction. Medscape medical news. Peer reviewed |
Demaret, I., Litran, G., Magoga, C., Deblire, C., Van Caillie, D., Lemaître, A., ANSSEAU, M., Quertemont, E. (Other coll.), DUBOIS, N. (Other coll.), CHARLIER, C. (Other coll.), & De Roubaix, J. (Other coll.). (2013). Projet TADAM: RAPPORT FINAL 2007-2013. Liège, Belgium: ULg - Université de Liège. https://orbi.uliege.be/handle/2268/160844 |
DUBOIS, N., HALLET, C., SEIDEL, L., Rozet, E., LUPPENS, D., ANSSEAU, M., Hubert, P., Albert, A., & Charlier, C. (October 2013). Estimation du délai entre la consommation d'héroïne et le prélèvement chez des consommateurs chroniques [Poster presentation]. 5èmes Journées Internationales de Toxicologie, Liège, Belgium. |
Demaret, I., Lemaître, A., & Ansseau, M. (May 2013). L'héroïne. Revue Médicale de Liège, 68 (5-6), 287. Peer reviewed |
BAKAY, S., IWEINS, A., Scantamburlo, G., Ansseau, M., & PITCHOT, W. (2013). Comment je traite ...la prise en charge de l'agitation en urgence. Revue Médicale de Liège, 68 (11), 553-6. Peer reviewed |
Scantamburlo, G., Ansseau, M., Geenen, V., & Legros, J.-J. (2013). INTRANASAL OXYTOCIN IN THE TREATMENT OF MAJOR DEPRESSION: A PILOT STUDY [Poster presentation]. GIGA-Day. |
DUBOIS, N., HALLET, C., LUPPENS, D., ANSSEAU, M., & Charlier, C. (2013). Sevrage rapide aux opiacés sous anesthésie (RODA). Revue Médicale de Liège, 68 (5-6), 298-302. Peer reviewed |
SCANTAMBURLO, G., PITCHOT, W., & Ansseau, M. (2013). La dependance affective. Revue Médicale de Liège, 68 (5-6), 340-7. Peer reviewed |
DUBOIS, N., Demaret, I., ANSSEAU, M., Rozet, E., Hubert, P., & Charlier, C. (2013). Plasma level monitoring of the major metabolites of diacetylmorphine (heroin) by the "chasing the dragon" route in severe heroin addicts. Acta Clinica Belgica, 68 (5), 359-367. doi:10.2143/ACB.3323 Peer Reviewed verified by ORBi |
DUBOIS, N., HALLET, C., SEIDEL, L., LUPPENS, D., ANSSEAU, M., Hubert, P., Albert, A., & Charlier, C. (2013). Estimation du délai entre la consommation d'héroïne et le prélèvement chez des consommateurs chroniques. Acta Clinica Belgica, 68 (6), 481. |
Scantamburlo, G., & Ansseau, M. (2013). Traitement du trouble bipolaire de type II. In J.-M. Aubry, F. FERRERO, ... N. SCHAAD (Eds.), Psychopharmacologie des Troubles Bipolaires (pp. 331-336). Genève, Switzerland: Médecine et Hygiène. Peer reviewed |
Scantamburlo, G., ANSSEAU, M., Geenen, V., & Legros, J.-J. (2013). AMELIORATION DE L’HUMEUR ET DE L’ANXIETE SOUS OCYTOCINE DANS LA DEPRESSION: ETUDE PILOTE. Encéphale (L'). Peer Reviewed verified by ORBi |
VANDER LAENEN, F., VANDERPLASSCHEN, W., SMET, V., DE MAEYER, J., BUCKINX, M., VAN AUDENHOVE, S., Ansseau, M., & DE RUYVER, B. (2013). Analysis and optimization of substitution treatment in Belgium (SUBANOP). Gent, Belgium: Academia Press. |
PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2013). Complications psychiatriques et addictions. Revue Médicale de Liège, 68 (5-6), 218-20. Peer reviewed |
Destoop, M., van den Eede, F., Ansseau, M., Albert, A., Vanbelle, S., Mignon, A., Slachmuylders, P., & Sabbe, B. (2013). Prevalence and clinical characteristics of remission during treatment in generalized anxiety. International Journal of Psychiatry in Clinical Practice, 17 (2), 90-7. doi:10.3109/13651501.2013.784789 Peer Reviewed verified by ORBi |
LE BON, O., Hansenne, M., AMARU, D., Albert, A., Ansseau, M., & DUPONT, S. (2013). Assortative mating and personality in human couples : A study using Cloninger's Temperament and Character Inventory. Psychology, 4 (1), 11-18. doi:10.4236/psych.2013.41002 Peer reviewed |
SCHOLL, J.-M., Philippe, P., Gérard, P., Magis, D., Nadel, J., Ansseau, M., & Delvenne, V. (20 December 2012). Duration perception: A Developmental Semiology from 2:6 to 13 Years, General Population versus Atypical, Assessment by Parental Questionnaire [Paper presentation]. 12e Journée des Doctorants, Bruxelles, Belgium. |
LICITSYNA, O., Ansseau, M., GERNAY, D., PITCHOT, W., & Bertrand, J. (2012). Sexual dysfunction induced by antidepressants and antipsychotics. Terapevticheskii Arkhiv, 84 (10), 103-8. Peer Reviewed verified by ORBi |
PITCHOT, W., & Ansseau, M. (2012). Efficacy of quetiapine in treatment-resistant panic disorder: a case report. Asian Journal of Psychiatry, 5 (2), 204-205. doi:10.1016/j.ajp.2012.02.013 Peer Reviewed verified by ORBi |
PITCHOT, W., Scantamburlo, G., Ansseau, M., & Souery, D. (2012). Le trouble bipolaire: une affection bien complexe. Revue Médicale de Liège, 67 (5-6), 366-373. Peer reviewed |
Ansseau, M., & PITCHOT, W. (2012). Les antidépresseurs. In F. Rouillon (Ed.), Manuel de Psychiatrie (2ème édition, pp. 575-586). Elsevier Masson. |
BAKAY, S., Scantamburlo, G., Ansseau, M., & PITCHOT, W. (2012). L'image du mois. Ingestion volontaire de corps etrangers: aspects psychiatriques. Revue Médicale de Liège, 67 (3), 105-106. Peer reviewed |
PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2012). Approche clinique et therapeutique de la depression chez la personne agee. Revue Médicale de Liège, 67 (11), 566-72. Peer reviewed |
Ansseau, M., SEIDEL, L., CROSSET, A., DIERCKXSENS, Y., & Albert, A. (2012). A dry extract of passiflora incarnata L. (Sedanxio) as first intention treatment of patients consulting for anxiety problems in general practice. Acta Psychiatrica Belgica, 112 (2), 5-11. Peer Reviewed verified by ORBi |
Mendlewicz, J., Crisafulli, C., Calati, R., Kocabas, A., Massat, I., LInotte, S., Kasper, S., Fink, M., Sidoti, A., Scantamburlo, G., Ansseau, M., Antonijevic, I., Forray, C., Snyder, L., Bollen, J., Montgomery, S., Zohar, J., Souery, D., & Serritti, A. (2012). Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression. Neuroscience Letters, 85-88. doi:10.1016/j.neulet.2012.03.063 Peer Reviewed verified by ORBi |
Demaret, I., Lemaître, A., & ANSSEAU, M. (2012). Staff concerns in heroin-assisted treatment centres. Journal of Psychiatric and Mental Health Nursing, 19, 563-567. doi:10.1111/j.1365-2850.2011.01810.x Peer Reviewed verified by ORBi |
DEBABECHE, C., Ansseau, M., & PITCHOT, W. (2012). Etat de stress post-traumatique et debriefing psychologique: un sujet controverse. Revue Médicale de Liège, 67 (1), 11-5. Peer reviewed |
Desseilles, M., Phillips, C., Matthews, Dang-Vu, T. T., Sterpenich, V., Albouy, G., Schmidt, C., Darsaud, A., Salmon, E., Vandewalle, G., Balteau, E., Degueldre, C., Luxen, A., ANSSEAU, M., Schwartz, S., & Maquet, P. (June 2011). Locus-coeruleus activation in patients with major depression and suicidal ideations. Abstract book of the conference [Paper presentation]. 17th Annual Meeting of the OHBM (Organization for Human Brain Mapping), Quebec, Canada. |
SCHOLL, J.-M., PHILIPPE, P., Pérée, F., Zdanowicz, N., & ANSSEAU, M. (April 2011). Une nouvelle conception des études sémiologiques : « l’épidémiologie sémiologique développementale ». Information Psychiatrique, 87 (4), 313-320. doi:10.1684/ipe.2011.0777 Peer Reviewed verified by ORBi |
Du Four, V., Ledent, M., Lilien, J.-L., & ANSSEAU, M. (2011). How as a transmission system operator (TSO) to respond to the growing public concern on the potential health effects of ELF exposure ? In Proceedings of the 2d International Conference on Extremely Low Frequency Electric and Magnetic fields (pp. 10). Peer reviewed |
Demaret, I., Herné, P., Lemaître, A., & ANSSEAU, M. (March 2011). Feasibility assessment of heroin-assisted treatment in Liège, Belgium. Acta Psychiatrica Belgica, 111 (1), 3-8. Peer Reviewed verified by ORBi |
Licitsyna, O., ANSSEAU, M., & PITCHOT, W. (2011). Effets secondaires sexuels des antidépresseurs. Revue Médicale de Liège. Peer reviewed |
PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2011). Les antidépresseurs du futur : rôle du système glutamatergique. Revue Médicale de Liège, 66 (4), 195-198. Peer reviewed |
HAIDON, M., PIETTE, C., ANSSEAU, M., & PITCHOT, W. (2011). Les troubles psychotiques dans les démences : quand la psychiatrie croise la neurologie. Acta Psychiatrica Belgica, 111 (11), 22-28. Peer Reviewed verified by ORBi |
PITCHOT, W., Scantamburlo, G., & Ansseau, M. (2011). Le cas clinique du mois. Syndrome sérotoninergique induit par une association isoniazide/venlafaxine. Revue Médicale de Liège, 66 (12), 611-613. Peer reviewed |
Demyttenaere, K., Ansseau, M., Constant, E., Albert, A., Van Gassen, G., & van Heeringen, K. (2011). Do general practitioners and psychiatrists agree about defining cure from depression? The DEsCRIBE (TM) survey. BMC Psychiatry, 11, 169. doi:10.1186/1471-244X-11-169 Peer Reviewed verified by ORBi |
PITCHOT, W., SCANTAMBURLO, G., & ANSSEAU, M. (2011). Les antidépresseurs tricycliques et les IMAO ont-ils encore une place dans le traitement de la dépression? Revue Médicale de Liège. Peer reviewed |
DEBABECHE, C., PIETTE, C., Ansseau, M., & PITCHOT, W. (2011). Le coma psychogène. Acta Psychiatrica Belgica, 111 (3), 20-25. Peer Reviewed verified by ORBi |
Desseilles, M., Schwartz, S., Dang Vu, T. T., Sterpenich, V., Ansseau, M., Maquet, P., & Phillips, C. (2011). Depression alters "top-down" visual attention: a dynamic causal modeling comparison between depressed and healthy subjects. NeuroImage, 54 (2), 1662-8. doi:10.1016/j.neuroimage.2010.08.061 Peer Reviewed verified by ORBi |
PITCHOT, W., SOUERY, D., & Ansseau, M. (2011). La dépression résistante : Définition et diagnostic. Acta Psychiatrica Belgica, 111 (4), 13-19. Peer Reviewed verified by ORBi |
Scantamburlo, G., Ansseau, M., Geenen, V., & Legros, J.-J. (2011). Intranasal oxytocin as an adjunct to escitalopram in major depression. Journal of Neuropsychiatry and Clinical Neurosciences, 23 (2), 5. doi:10.1176/jnp.23.2.jnpe5 Peer Reviewed verified by ORBi |
Noro, M., Linotte, S., Ansseau, M., Balériaux, D., Kavec, M., Mendlewicz, J., Metens, T., Scantamburlo, G., Souery, D., Verbanck, P., Peigneux, P., & Massat, I. (2011). Exploration neurodéveloppementale de la mémoire de travail par neuroimagerie fonctionnelle. Encéphale (L'), 37, 179-180. Peer Reviewed verified by ORBi |
PITCHOT, W., SCANTAMBURLO, G., & ANSSEAU, M. (2011). La dépression résistante : Définition et diagnostique. Acta Psychiatrica Belgica. Peer Reviewed verified by ORBi |
HITABATUMA, H., Papart, P., WAUTHY, J., BARTHOLOME, F., & Ansseau, M. (2011). Le modèle psychologique de Cloninger (TCI) et la dépression. Acta Psychiatrica Belgica, 111 (3), 34-38. Peer Reviewed verified by ORBi |
Esch, P., Bocquet, V., Pull, C., Couffignal, S., Graas, M., Lair, M.-L., Lehnert, T., Fond-Harmant, L., & Ansseau, M. (2011). Psychosocial risk and protective factors of secondary school dropout in Luxembourg: the protocol of an exploratory case-control study. BMC Public Health, 11, 555. doi:10.1186/1471-2458-11-555 Peer Reviewed verified by ORBi |
Licitsyna, O., ANSSEAU, M., & PITCHOT, W. (2011). Dysfonctions sexuelles et antidépresseurs. Revue Médicale de Liège, 66 (2), 69-74. |
Demaret, I., Lemaître, A., & Ansseau, M. (December 2010). L’efficacité du traitement assisté par diacétylmorphine (héroïne pharmaceutique) à l’étranger. Revue Médicale de Liège, 65 (12), 681-687. Peer reviewed |
Demaret, I., Litran, G., ANSSEAU, M., & Lemaître, A. (08 September 2010). Heroin-Assisted Treatment as a treatment of criminal behaviour? [Paper presentation]. 10th Annual Conference of the European Society of Criminology - Crime and Criminology: from Individuals to Organizations, Liège, Belgium. |
Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang-Vu, T., Albouy, G., Schmidt, C., Degueldre, C., Phillips, C., Ansseau, M., Maquet, P., & Schwartz, S. (June 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients. Abstract Book of the congress [Paper presentation]. World Congress of Behavioral and Cognitive Therapies (WCBCT), Boston, United States. |
Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang-Vu, T., Albouy, G., Schmidt, C., Degueldre, C., Phillips, C., Ansseau, M., Maquet, P., & Schwartz, S. (May 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients.Abstract Book of the conference [Paper presentation]. 163rd Annual Meeting of the American Psychiatric Association (APA), New- Orleans J, United States. |
Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang Vu, T. T., Albouy, G., Schmidt, C., Degueldre, C., Phillips, C., Ansseau, M., Maquet, P., & Schwartz, S. (April 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients. Abstract Book of the conference [Paper presentation]. 17th Annual Meeting of the Cognitive Neuroscience Society, Montreal, Canada. |
Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang-Vu, T., Schmidt, C., Ansseau, M., Maquet, P., & Schwartz, S. (March 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients. Abstract Book of the conference [Paper presentation]. Swiss Society of Neurosciences (SSN) Annual Meeting 2010, Lausanne, Switzerland. |
Maquet, D., Croisier, J.-L., Dupont, C., Moutschen, M., Ansseau, M., Zeevaert, B., & Crielaard, J.-M. (2010). Fibromyalgia and related conditions: Electromyogram profile during isometric muscle contraction. Joint Bone Spine, 77, 264–267. doi:10.1016/j.jbspin.2010.02.003 Peer Reviewed verified by ORBi |
Scantamburlo, G., Ansseau, M., Geenen, V., & Legros, J.-J. (2010). Intranasal oxytocin as an antidepressant/anxiolytic hormone in the treatment of major depression: a case report. |
Scantamburlo, G., Reggers, J., Hansenne, M., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2010). Ocytocine plamsatique et dimensions de personnalité dans la dépression unipolaire. Encéphale (L'), 36, 17. Peer Reviewed verified by ORBi |
PITCHOT, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2010). Guérir la dépression : une question d'objectif et de détermination. Revue Médicale de Liège, 65 (5-6), 370-380. Peer reviewed |
BEVE, A., BECK, E., Pinto, E., & Ansseau, M. (2010). Le cas clinique du mois. Syndrome de sécrétion inappropriée d'hormone antidiurétique (SIADH) induit par le valproate de sodium. Revue Médicale de Liège, 65 (1), 6-9. Peer reviewed |
Farcy, L., PIETTE, C., MAVROPOULOS, G., Pinto, E., Ansseau, M., & PITCHOT, W. (2010). Delirium et anorexie. Acta Psychiatrica Belgica, 110, 3-7. Peer Reviewed verified by ORBi |
PITCHOT, W., SCANTAMBURLO, G., & ANSSEAU, M. (2010). Duloxetine in major depressed patients resistant to SSRI and/or venlafaxine. Psychiatria Danubina. Peer Reviewed verified by ORBi |
Maquet, D., Croisier, J.-L., Dupont, C., Moutschen, M., Ansseau, M., Zeevaert, B., & Crielaard, J.-M. (2010). Fibromyalgie et affections voisines : analyse du comportement électromyographique au cours d’un effort musculaire isométrique. Revue du Rhumatisme, 77, 296-300. doi:10.1016/j.rhum.2009.10.026 Peer Reviewed verified by ORBi |
Quertemont, E., Blairy, S., & Ansseau, M. (2010). Effets du cannabis sur la santé psychologique. Regards Croisés sur le Cannabis. Mardaga. |
Pitchot, W., & Ansseau, M. (2010). Aripiprazole, hypertension, and confusion. Journal of Neuropsychiatry and Clinical Neurosciences, 22 (1), 123.E33. doi:10.1176/appi.neuropsych.22.1.123-t.e33 Peer Reviewed verified by ORBi |
Desseilles, M., Muselle, A., Devue, C., Sterpenich, V., Dang-Vu, T., Schmidt, C., Ansseau, M., Maquet, P., & Schwartz. (January 2010). Cognitive modulation of fronto-striatal networks in obsessivecompulsive disorder patients [Paper presentation]. Alpine Brain Imaging Meeting, Champéry, Switzerland. |
Quertemont, E., Blairy, S., & Ansseau, M. (2010). Effets du cannabis sur la santé psychologique. In V. Seutin, J. Scuvée, ... E. Quertemont (Eds.), Regards croisés sur le cannabis (pp. 105-122). Wavre, Belgium: Mardaga. |
Desseilles, M., Muselle, A., Devue, C., Balteau, E., Sterpenich, V., Dang-Vu, T. T., Albouy, G., Schmidt, C., Matarazzo, L., Mascetti, L., Foret, A., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (July 2009). Increased filtering of irrelevant information in obsessive-compulsive disorder (OCD) patient. Abstract Book [Paper presentation]. 1st Congress of International College of Affective Neurosciences, Florence, Italy. |
Desseilles, M., Muselle, A., Devue, C., Balteau, E., Sterpenich, V., Dang-Vu, T. T., Albouy, G., Schmidt, C., Matarazzo, L., Mascetti, L., Foret, A., Degueldre, C., Luxen, A., Ansseau, M., Maquet, P., Schwartz, S., & Phillips, C. (June 2009). Abnormal neural filtering of irrelevant information in depressed patients [Poster presentation]. 15th Annual Meeting of the OHBM (Organization for Human Brain Mapping), San Francisco, United States. |
Pinto, E., Reggers, J., Gorwood, P., Boni, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2009). The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease? Alcohol, 43 (4), 271-5. doi:10.1016/j.alcohol.2009.02.006 Peer reviewed |
Pitchot, W., & Ansseau, M. (2009). Dependance au zolpidem et crise d'epilepsie. Revue Médicale de Liège, 64 (7-8), 407-8. Peer reviewed |
Desseilles, M., Thiry, J.-C., Monville, J.-F., Ansseau, M., & Makhinson, M. (2009). Electroconvulsive therapy for depression in a patient with an intracranial arachnoid cyst. Journal of ECT, 25 (1), 64-6. doi:10.1097/YCT.0b013e3181729268 Peer Reviewed verified by ORBi |
Ansseau, M., Demyttenaere, K., Heyrman, J., Migeotte, A., Leyman, S., & Mignon, A. (2009). Objective: remission of depression in primary care The Oreon Study. European Neuropsychopharmacology, 19 (3), 169-76. doi:10.1016/j.euroneuro.2008.10.003 Peer Reviewed verified by ORBi |
Desseilles, M., Balteau, E., Sterpenich, V., Dang Vu, T. T., Darsaud, A., Vandewalle, G., Albouy, G., Salmon, E., Peters, F., Schmidt, C., Schabus, M., Gais, S., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (2009). Abnormal neural filtering of irrelevant visual information in depression. Journal of Neuroscience, 29 (5), 1395-403. doi:10.1523/JNEUROSCI.3341-08.2009 Peer Reviewed verified by ORBi |
Desseilles, M., Muselle, A., Devue, C., Balteau, E., Sterpenich, V., Dang Vu, T. T., Albouy, G., Schmidt, C., Matarazzo, L., Mascetti, L., Foret, A., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (2009). Increased filtering of irrelevant information in obsessive-compulsive disorder (OCD) patient [Poster presentation]. First Congress of International College of Affective Neurosciences, Firenza, Italy. |
Pinto, E., & Ansseau, M. (2009). Facteurs genetiques de l'alcoolo-dependance Revue des principales donnees de la litterature. Encéphale (L'), 35 (5), 461-9. doi:10.1016/j.encep.2008.03.008 Peer Reviewed verified by ORBi |
Desseilles, M., Schwartz, S., & Ansseau, M. (2009). Méthode d’évaluation de l’efficacité des psychotherapies: impact de la neuroimagerie fonctionnelle [Paper presentation]. 7e congrès de l’Encéphale, Paris, France. |
Scantamburlo, G., Ansseau, M., Geenen, V., & Legros, J.-J. (2009). Oxytocin: From milk ejection to maladaptation in stress response and psychiatric disorders. A psychoneuroendocrine perspective. Annales d'Endocrinologie, 70 (6), 449-54. doi:10.1016/j.ando.2009.09.002 Peer Reviewed verified by ORBi |
Zelinka, V., Faymonville, M.-E., Pitchot, W., & Ansseau, M. (2009). L'hypnose dans la prise en charge des douleurs chroniques. Acta Psychiatrica Belgica, 109 (3), 21-28. Peer Reviewed verified by ORBi |
Desseilles, M., Balteau, E., Sterpenich, V., Dang Vu, T., Darsaud, A., Vandewalle, G., Albouy, G., Salmon, E., Peters, F., Schmidt, C., Schabus, M., Gais, S., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (2009). Abnormal neural filtering of irrelevant visual information in depression. NeuroImage, 45 (Suppl. 1). Peer Reviewed verified by ORBi |
Desseilles, M., Scwartz, S., Dang Vu, T., Sterpenich, V., Albouy, G., Schmidt, C., Salmon, E., Darsaud, A., Vandewalle, G., Balteau, E., Degueldre, C., Luxen, A., Ansseau, M., & Maquet, P. (2009). Neurobiological bases of suicidality in major depression. World Journal of Biological Psychiatry, 9 (Suppl. 1). Peer Reviewed verified by ORBi |
Desseilles, M., Schwartz, S., Ansseau, M., & Maquet, P. (January 2009). Neurobiological Bases of Suicidality in Major Depression Abstract Book of the conference [Paper presentation]. Alpine Brain Imaging Meeting, Champéry, Switzerland. |
Desseilles, M., Balteau, E., Sterpenich, V., Dang-Vu, T. T., Darsaud, A., Vandewalle, G., Albouy, G., Salmon, E., Peters, F., Schmidt, C., Schabus, M., Gais, S., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (11 July 2008). Abnormal neural filtering of irrelevant information in depressed patients Abstract Book of the conference [Paper presentation]. Symposium of the International Master in Affective Neuroscience, Florence, Italy. |
Moonen, G., Ansseau, M., & Scheen, A. (May 2008). Le cerveau dans tous ses etats. Revue Médicale de Liège, 63 (5-6), 229-30. Peer reviewed |
Desseilles, M., Balteau, E., Sterpenich, V., Dang-Vu, T. T., Darsaud, A., Vandewalle, G., Albouy, G., Salmon, E., Peters, F., Schmidt, C., Schabus, M., Gais, S., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., Maquet, P., & Schwartz, S. (15 March 2008). Abnormal neural filtering of irrelevant information in depressed patients. Abstract Book of the congress [Paper presentation]. 1ère Journée de l'Ecole Doctorale en Médecine Clinique et Expérimentale FRS-FNRS, Bruxelles, Belgium. |
Tortolani, I., Gayetot, D., Duquesne, P., Donneau, A.-F., Boxho, P., & Ansseau, M. (2008). L'augmentation des hospitalisations contraintes : un constat préoccupant. Acta Psychiatrica Belgica, 108, 11-19. Peer Reviewed verified by ORBi |
Pitchot, W., Paquay, C., & Ansseau, M. (2008). Le comportement suicidaire: facteurs de risque psychosociaux et psychiatriques. Revue Médicale de Liège, 63, 396-403. Peer reviewed |
Pitchot, W., Scantamburlo, G., & Ansseau, M. (2008). Dopamine et dépression: le neurotransmetteur oublié. Revue Médicale de Liège, 63, 378-384. Peer reviewed |
Ansseau, M., Fischler, B., Dierick, M., Albert, A., Leyman, S., & Mignon, A. (2008). Socio-economic correlates of generalized anxiety disorder and major depression in primary care : The GADIS II study (Generalized Anxiety and Depression Impact Survey II). Depression and Anxiety, 25, 506-513. doi:10.1002/da.20306 Peer Reviewed verified by ORBi |
Pitchot, W., & Ansseau, M. (2008). Shock-like sensations associated with duloxetine discontinuation. Annals of Clinical Psychiatry, 20 (3), 175. doi:10.1080/10401230802177664 Peer Reviewed verified by ORBi |
Pitchot, W., Scantamburlo, G., Pinto, E., Hansenne, M., Reggers, J., Ansseau, M., & Legros, J.-J. (2008). Vasopressin-neurophysin and DST in major depression : Relationship with suicidal behavior. Journal of Psychiatric Research, 42, 684-688. doi:10.1016/j.jpsychires.2007.07.007 Peer Reviewed verified by ORBi |
Pinto, E., Pitchot, W., & Ansseau, M. (2008). Les psychostimulants. Revue Médicale de Liège, 63, 411-416. Peer reviewed |
Maquet, D., Jaspar, J., Lecart, M.-P., Faymonville, M., Crielaard, J.-M., Bève, E., Ansseau, M., Pinto, E., Haidon, M., & Croisier, J.-L. (2008). La marche du sujet fibromyalgique et d’un sujet dépressif est-elle différenciable ? Exploration de deux affections « voisines » à partir d’un accéléromètre tri-axial. Revue du Rhumatisme, 75, 1142. Peer reviewed |
Ansseau, M., Scantamburlo, G., Pinto, E., & Pitchot, W. (2008). Neurobiologie et pharmacothérapie du trouble obsessionnel-compulsif. Revue Médicale de Liège, 63, 359-363. Peer reviewed |
Moonen, G., Ansseau, M., & Scheen, A. (2008). Editorial. Le cerveau dans tous ses états. Revue Médicale de Liège, 63, 229-230. Peer reviewed |
Pitchot, W., Polis, M.-H., Belachew, S., & Ansseau, M. (2008). Dépression et neuroplasticité. Revue Médicale de Liège, 63, 372-377. Peer reviewed |
Papart, P., Ansseau, M., & Bartholomé, F. (2008). Contingent negative variation abnormalities in posttraumatic stress disorder. European Neuropsychopharmacology, 18 (Suppl 4), 481-482. Peer Reviewed verified by ORBi |
Scantamburlo, G., Ansseau, M., & Legros, J.-J. (2008). Growth Hormone Response to Apomorphine and Clonidine Stimulation in Psychiatric Disorders. In New Human Growth hormone (pp. 135-145). New York, United States - New York: Nova Biomedical Book. Peer reviewed |
hurlet, A., parent, M., Lecoq, A., & Ansseau, M. (2008). Un cas de folie à trois. Acta Psychiatrica Belgica, 108, 18-24. Peer Reviewed verified by ORBi |
Pitchot, W., Scantamburlo, G., & Ansseau, M. (2008). Les antidépresseurs dans la dépression bipolaire: attention aux risques. Revue Médicale de Liège, 63, 391-395. Peer reviewed |
Pinto, E., Reggers, J., Gorwood, P., BONI, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2008). The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol and Alcoholism, 43, 398-400. doi:10.1093/alcalc/agn015 Peer Reviewed verified by ORBi |
Servais, S., Ansseau, M., Mikolajczak, G., & Desseilles, M. (2008). L'électroconvulsivothérapie en 2008. Revue Médicale de Liège, 63, 404-410. Peer reviewed |
Desseilles, M., Ansseau, M., Maquet, P., & Schwartz, S. (2008). Rôle de l'attention et de l'émotion dans la perception visuelle : leurs implications dans les troubles neurocognitifs de la dépression. Acta Psychiatrica Belgica, 108, 20-24. Peer Reviewed verified by ORBi |
Scantamburlo, G., Pitchot, W., Ansseau, M., & Legros, J.-J. (2008). Peptides neurohypophysaires et dépression unipolaire: quel avenir? Revue Médicale de Liège, 63, 385-390. Peer reviewed |
Desseilles, M., Maquet, P., Darsaud, A., Dang-Vu, T. T., Sterpenich, V., Albouy, G., Ansseau, M., & Schwartz, S. (2008). Anomalies du filtrage neuronal des informations non-relevantes chez les patients déprimés (PO31) [Paper presentation]. 6e Congrès de l'Encéphale, Paris, France. |
Desseilles, M., Maquet, P., Ansseau, M., & Schwartz, S. (15 December 2007). Attention and perception in depression assessed by functional magnetic resonance imaging [Paper presentation]. Lecture at the international session of “Cognitive functions and pharmacotherapy”, Wisla, Poland. |
Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Marechal, P., Pequeux, C., Ansseau, M., & Legros, J.-J. (May 2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology, 32 (4), 407-410. doi:10.1016/j.psyneuen.2007.01.009 Peer Reviewed verified by ORBi |
Lorant, V., Croux, C., Weich, S., Deliege, D., Mackenbach, J., & Ansseau, M. (April 2007). Depression and socio-econornic risk factors: 7-year longitudinal population study. British Journal of Psychiatry, 190, 293-298. doi:10.1192/bjp.bp.105.020040 Peer Reviewed verified by ORBi |
Desseilles, M., Maquet, P., Dang Vu, T. T., Sterpenich, V., Vandewalle, G., Peters, F., Darsaud, A., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., & Schwartz, S. (April 2007). Effects of attention on emotional face processing in depression: a functional MRI study [Poster presentation]. Conference on Depression: Brain Causes - Body Consequences, London, United Kingdom. |
Desseilles, M., Ansseau, M., Maquet, P., & Schwartz, S. (10 March 2007). Rôle de l’attention et de l’émotion dans la perception visuelle : implications pour les troubles neurocognitifs dans la dépression. Abstract Book of the congress [Paper presentation]. Meeting of the S.R.M.M.B. (Belgian Royal Society for Mental Medicine), Bruxelles, Belgium. |
Pitchot, W., Pinto, E., Scantamburlo, G., & Ansseau, M. (March 2007). Duloxetine in major depressed patients resistant to SSRIs or venlafaxine. European Psychiatry, 22 (Suppl. 1), 242. doi:10.1016/j.eurpsy.2007.01.810 Peer Reviewed verified by ORBi |
Gayetot, D., Ansseau, M., & Triffaux, J.-M. (February 2007). "Quand la dépression n'en finit pas... " Stratégies actuelles et perspectives thérapeutiques de la dépression résistante. Revue Médicale de Liège, 62 (2), 103-11. Peer reviewed |
Desseilles, M., Ansseau, M., Maquet, P., & Schwartz, S. (22 January 2007). Attention and perception in depression assessed by fonctional resonance imaging [Paper presentation]. Meeting of the Academic Anxiety Center, Maastricht, Netherlands. |
Coton, X., Pinto, E., Reggers, J., Hansenne, M., Parent, M., & Ansseau, M. (2007). Impact de la personnalité sur l'intensité du syndrome de sevrage alcoolique : une étude préliminaire avec le modèle de Cloninger. Encéphale (L'), 33, 264-269. doi:10.1016/s0013-7006(07)92038-2 Peer Reviewed verified by ORBi |
Desseilles, M., Maquet, P., Dang Vu, T. T., Sterpenich, V., Vandewalle, G., Peters, F., Darsaud, A., Degueldre, C., Phillips, C., Luxen, A., Ansseau, M., & Schwartz, S. (2007). Effects of attention on emotional face processing in depression : a functional MRI study [Poster presentation]. Conference on depression : brain causes - body consequences, London, United Kingdom. |
Pitchot, W., & Ansseau, M. (2007). Les troubles de l'humeur: approche pharmacologique. Revue Médicale de Liège, 62 (S2), 21-4. Peer reviewed |
Le Bon, O., Cappeliez, B., Neu, D., Stulens, L., Hoffmann, G., Hansenne, M., Lambrecht, L., Ansseau, M., & Linkowski, P. (2007). Personality profile of patients with chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome, 14, 55-68. doi:10.1300/j092v14n01_06 Peer Reviewed verified by ORBi |
Pitchot, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2007). Syndrome de discontinuation associé aux antidépresseurs. Revue Médicale de Liège, 62, 1-4. Peer reviewed |
Desseilles, M., Maquet, P., Sterpenich, V., Vandewalle, G., Peters, F., Dang-Vu, T. T., Darsaud, A., Degueldre, C., Ansseau, M., & Schwartz, S. (2007). Effects of attention and emotion on face processing in depression: a functional magnetic resonance imaging study [Paper presentation]. 20th ECNP (European College of Neuropsychopharmacology) Congress, Vienna, Austria. |
Scantamburlo, G., Ansseau, M., & Legros, J.-J. (2007). Neurophysins in mood disorders. In Neuropeptide Research Trends (pp. 229-241). New-York, United States - New York: Nova Biomedical Book. Peer reviewed |
Ansseau, M., & Pitchot, W. (2007). Les antidépresseurs. In J. D. Guelfi & F. Rouillon (Eds.), Manuel de Psychiatrie (pp. 504-515). Paris, France: Masson. |
Pitchot, W., & Ansseau, M. (2007). Nouveautés dans le traitement des troubles de l'humeur. Acta Psychiatrica Belgica, 107, 21-22. Peer Reviewed verified by ORBi |
Pitchot, W., & Ansseau, M. (2007). Hypothalamo-growth hormone dysfunction in panic disorder. Acta Psychiatrica Belgica, 107, 21-22. Peer Reviewed verified by ORBi |
Hadoun, K., Ansseau, M., Bertand, J., & Lejeune, J. (2007). Influence de l'âge du médecin généraliste sur la prise en charge de la dépression. Acta Psychiatrica Belgica, 107, 55-65. doi:10.1007/s10597-018-0335-8 Peer Reviewed verified by ORBi |
Desseilles, M., Thiry, J. C., Abramowski, S., Pallincourt, R., Farcy, L., Zelinka, V., Fush, S., & Ansseau, M. (January 2007). Electroconvulsivothérapie chez un patient déprimé avec un kyste arachnoïdien intracrânien [Paper presentation]. 5e Congrès de l’Encéphale, Paris, France. |
Scantamburlo, G., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2007). Therapeutic utilisations of vasopressin and oxytocin in mood disorders. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, 1, 157-161. Peer reviewed |
Foatelli, F.-M., Gernay, P., Lievens, I., & Ansseau, M. (December 2006). Le cas clinique du mois. Syndrome malin des neuroleptiques et paralysie generale. Revue Médicale de Liège, 61 (12), 807-11. Peer reviewed |
Desseilles, M., Ansseau, M., Maquet, P., & Schwartz, S. (18 November 2006). Effects of attention on emotional face processing in depression: a functional MRI study. Abstract Book of the congress [Paper presentation]. Highlights in psychiatry 2006 session, Bruxelles, Belgium. |
Desseilles, M., Maquet, P., Sterpenich, V., Vandewalle, G., Peters, F., Darsaud, A., Degueldre, C., Luxen, A., Ansseau, M., & Schwartz, S. (18 November 2006). Effects of attention on emotional face processing in depression: an fMRI study [Poster presentation]. Highlights in Psychiatry, Brussels, Belgium. |
Papart, P., Liota, F., Bartholome, F., & Ansseau, M. (September 2006). Cognitive topography imbalance in alcoholism and psychiatric comorbidity. European Neuropsychopharmacology, 16 (Suppl. 4), 496. doi:10.1016/S0924-977X(06)70671-X Peer Reviewed verified by ORBi |
Ansseau, M., Reggers, J., Somers, L., Richy, F., Van Deun, P., & Sabbe, B. (September 2006). Meta-analyses of opiate maintenance therapies. European Neuropsychopharmacology, 16 (Suppl. 4), 503. doi:10.1016/S0924-977X(06)70684-8 Peer Reviewed verified by ORBi |
Lorant, V., Croux, C., Weich, S., Deliege, D., Mackenbach, J., & Ansseau, M. (September 2006). Depression and socio-economic status: an 8-year longitudinal population-based study. European Neuropsychopharmacology, 16 (Suppl. 4), 294-S295. doi:10.1016/S0924-977X(06)70301-7 Peer Reviewed verified by ORBi |
Desseilles, M., Schwartz, S., Dang Vu, T. T., Sterpenich, V., Darsaud, A., Albouy, G., Vandewalle, G., Gais, S., Schabus, M., Rauchs, G., Degueldre, C., Luxen, A., Ansseau, M., & Maquet, P. (September 2006). Effects of attention and emotion on face processing in depression: a functional MRI study. The Journal of the European College of Neuropsychopharmacology, 16 (supplement 4), 271. Peer reviewed |
Linotte, S., Barreto, M., Van Geit, N., D'haenen, H., Vanderkelen, P., Schepers, N., Scantamburlo, G., Pitchot, W., Ansseau, M., Van der Auwera, K., Bollen, J., Souery, D., & Mendlewicz, J. (September 2006). Clinical characteristics of depressive episodes in Bipolar I and Bipolar II disorders. European Neuropsychopharmacology, 16 (Suppl. 4), 301. doi:10.1016/S0924-977X(06)70314-5 Peer Reviewed verified by ORBi |
Desseilles, M., Schwartz, S., Dang-Vu, T. T., Sterpenich, V., Darsaud, A., Albouy, G., Vandewalle, G., Gais, S., Schabus, M., Rauchs, G., Degueldre, C., Luxen, A., Ansseau, M., & Maquet, P. (September 2006). Effects of attention and emotion on face processing in depression: a functional MRI study. European Neuropsychopharmacology, 16 (Suppl. 4), 271. doi:10.1016/S0924-977X(06)70257-7 Peer Reviewed verified by ORBi |
David, H. N., Ansseau, M., Lemaire, M., & Abraini, J. H. (01 July 2006). Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization. Biological Psychiatry, 60 (1), 49-57. doi:10.1016/j.biopsych.2005.10.007 Peer Reviewed verified by ORBi |
Laloyaux, O., Ansseau, M., & Hansenne, M. (2006). Impact of low-frequency transcranial magnetic stimulation on brain automatic information processing - A mismatch negativity study. Journal of Psychophysiology, 20 (4), 267-275. doi:10.1027/0269-8803.20.4.267 Peer reviewed |
Polis, M.-H., Pitchot, W., & Ansseau, M. (2006). Dépression et neuroplasticité : des découvertes neuroanatomiques aux nouvelles stratégies thérapeutiques. Acta Psychiatrica Belgica, 106 (1), 20-31. Peer Reviewed verified by ORBi |
Ansseau, M., Dierick, M., Buntinx, F., Cnockaert, P., De Smedt, J., Van Den Haute, M., & Vander Mijnsbrugge, D. (2006). Hoge prevalentie van mentale stoornissen in de eerste lijn. Resultaten van een cross-sectioneel onderzoek. Huisarts Nu, 35, 499-505. |
Scantamburlo, G., Hansenne, M., Fuchs, S., PITCHOT, W., Reggers, J., ANSSEAU, M., & Legros, J.-J. (2006). OXYTOCIN, VASOPRESSIN AND ANXIETY IN MAJOR DEPRESSION: AGO-ANTAGONIST NEUROHROMONES. European Neuropsychopharmacology, 16, 306-S307. Peer Reviewed verified by ORBi |
De Grégorio, F., Damsa, C., Adam, E., Reggers, J., Lazignac, C., & Ansseau, M. (2006). L'utilisation du système de santé avant un passage à l'acte suicidaire : étude préliminaire dans un service d'urgences psychiatriques. Annales Médico-Psychologiques, 164 (7), 574-580. doi:10.1016/j.amp.2006.06.006 Peer Reviewed verified by ORBi |
Reggers, J., SOMERS, L., Richy, F., VAN DEUN, P., SABBE, B., & Ansseau, M. (Eds.). (2006). Intérêt des traitements de substitution dans la dépendance aux opiacés. Gent, Belgium: Academia Press. |
Desseilles, M., Fuchs, S., Ansseau, M., Lopez, S., Vinckenbosh, E., & Andreoli, A. (2006). Achalasia may mimic anorexia nervosa, compulsive eating disorder, and obesity problems. Psychosomatics, 47 (3), 270-1. doi:10.1176/appi.psy.47.3.270 Peer Reviewed verified by ORBi |
Ansseau, M. (2006). Le temps de l'anxiété. Tempo Médical, 279, 19-20. Peer reviewed |
Desseilles, M., Maquet, P., Sterpenich, V., Vandewalle, G., Peters, F., Darsaud, A., Degueldre, C., Luxen, A., Ansseau, M., & Schwartz, S. (2006). Effects of attention on emotional face processing in depression : a functional MRI study [Poster presentation]. Highlights in Psychiatry, Bruxelles, Belgium. |
Ansseau, M. (2006). Utilité des antidépresseurs dans les troubles anxieux. Revue Médicale Suisse, 2 (76), 1885-1891. Peer Reviewed verified by ORBi |
Pitchot, W., & Ansseau, M. (2006). Rôle des récepteurs 5-HT1A dans le comportement suicidaire. Neurone, 11, 90-94. |
David, H. N., Ansseau, M., & Abraini, J. H. (15 December 2005). Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals. Brain Research Reviews, 50 (2), 336-360. doi:10.1016/j.brainresrev.2005.09.002 Peer Reviewed verified by ORBi |
Reggers, J., Somers, L., Richy, F., Van Deun, P., Sabbe, B., & Ansseau, M. (2005). Efficacité et efficience des molécules substitutives dans le traitement de la dépendance aux opiacés. (DR/17). Belgium: Service de Programmation Fédérale – Politique Scientifique Fédérale. https://orbi.uliege.be/handle/2268/264628 |
Scantamburlo, G., Fuchs, S., Pitchot, W., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2005). Plasma oxytocin and anxiety in depressed patients. European Neuropsychopharmacology, 15 (Suppl. 3), 430. Peer Reviewed verified by ORBi |
Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2005). AVP- and OT-neurophysins response to apomorphine and clonidine in major depression. Psychoneuroendocrinology, 30 (9), 839-845. doi:10.1016/j.psyneuen.2005.04.015 Peer Reviewed verified by ORBi |
Ansseau, M., Fischler, B., Dierick, M., Mignon, A., & Leyman, S. (May 2005). Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: the GADIS study. European Psychiatry, 20 (3), 229-235. doi:10.1016/j.eurpsy.2004.09.035 Peer Reviewed verified by ORBi |
Scantamburlo, G., Ansseau, M., & Legros, J.-J. (March 2005). Neurophysins response to apomorphine and clonidine in major depression. European Neuropsychopharmacology, 15 (Suppl. 1), 77-S78. doi:10.1016/S0924-977X(05)80201-9 Peer Reviewed verified by ORBi |
Ansseau, M. (February 2005). Critères prédictifs de l'évolution d'un accès maniaque. Encéphale (L'), 31 (Pt 2), 38-41. Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2005). 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. Biological Psychiatry, 58 (11), 854-8. doi:10.1016/j.biopsych.2005.05.042 Peer Reviewed verified by ORBi |
Ansseau, M. (2005). La dépression : la réponse thérapeutique (3/3). Tempo Médical, 274, 109-110. Peer reviewed |
Ansseau, M. (2005). Evaluatie van de activiteit van capsules droogextract van passiebloem, volgens een "ster"-model. Farmaceutisch Tijdschrift voor Belgie, (2), 11-14. Peer reviewed |
Ansseau, M. (2005). La dépression : les vérités tout terrain (1/3). Tempo Médical, (272), 57-58. Peer reviewed |
Ansseau, M. (2005). La dépression : au cœur du mal (2/3). Tempo Médical, 272, 57-58. Peer reviewed |
Ansseau, M. (2005). Obsessive-compulsive personality disorder: Response to pharmacological treatment. In M. Maj, H. S. Akiskal, J. E. Mezzich, ... A. Okasha (Eds.), Personality Disorders (pp. 468-471). Chichester, United Kingdom: Wiley & Sons, Ltd. |
Guillon, M. S., Crocq, M. A., Bartholomé, F., Macher, J. P., & Ansseau, M. (2005). Estime de soi et troubles psychiatriques à l'adolescence. Acta Psychiatrica Belgica, 105 (2), 103-109. Peer Reviewed verified by ORBi |
ANSSEAU, M. (2005). Obsessive-compulsive personality disorder: Response to pharmacological treatment. In M. Maj, Personality disorders (pp. 468-471). Chichester, United Kingdom: John Wiley & Sons, Ltd. doi:10.1002/0470090383.ch6 |
Ansseau, M. (2005). Actualités autour des troubles affectifs. Tempo Médical, (274), 24-25. Peer reviewed |
Ansseau, M., Gustin, F., Hodiaumont, F., Lemaître, A., Lo Bue, S., Lorant, V., Portet, M.-I., Reggers, J., Tyberghein, M., & Van Deun, P. (2005). DHCo Délivrance d'héroïne sous contrôle médical. Gand, Belgium: Academia Press. |
Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2004). Neurohypophyseal response to apomorphine and clonidine stimulation in major depression. European Neuropsychopharmacology, 14 (Suppl. 3), 291-S292. doi:10.1016/S0924-977X(04)80355-9 Peer Reviewed verified by ORBi |
Fuchs, S., Reggers, J., Pinto, E., Scantamburlo, G., Pitchot, W., Hansenne, M., Maertens De Noordhout, A., & Ansseau, M. (October 2004). Therapeutic application of right prefrontal low repetitive transcranial magnetic stimulation on depressed patients. European Neuropsychopharmacology, 14 (Suppl. 3), 226. doi:10.1016/S0924-977X(04)80206-2 |
Reggers, J., Ansseau, M., Gustin, F., Pirard, S., van Deun, P., Seghers, A., Earley, P., Besson, J., & Gastfriend, D. (October 2004). Adaptation and validation of the ASAM PPC-2R criteria in French and Dutch speaking Belgian drug-addicts. European Neuropsychopharmacology, 14 (Suppl. 3), 354-S355. Peer Reviewed verified by ORBi |
Ansseau, M., Demyttenaere, K., Heyrman, J., Migeotte, A., Leyman, S., & Mignon, A. (June 2004). OREON: Observation of remission in depression in primary and psychiatric care. International Journal of Neuropsychopharmacology, 7 (Suppl. 1), 167. Peer Reviewed verified by ORBi |
Scantamburlo, G., & Ansseau, M. (May 2004). L'attaque de panique. Revue Médicale de Liège, 59 (5), 293-6. Peer reviewed |
Pinto, E., & Ansseau, M. (May 2004). Les alcoolisations paroxystiques. Revue Médicale de Liège, 59 (5), 297-300. |
Pitchot, W., Wauthy, J., Legros, J.-J., & Ansseau, M. (March 2004). Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study. European Neuropsychopharmacology, 14 (2), 151-155. doi:10.1016/S0924-977X(03)00108-1 Peer Reviewed verified by ORBi |
Le Bon, O., Basiaux, P., Streel, E., Tecco, J., Hanak, C., Hansenne, M., Ansseau, M., Pelc, I., Verbanck, P., & Dupont, S. (2004). Personality profile and drug of choice; a multivariate analysis using Cloninger's TCI on heroin addicts, alcoholics, and a random population group. Drug and Alcohol Dependence, 73 (2), 175-82. doi:10.1016/j.drugalcdep.2003.10.006 Peer Reviewed verified by ORBi |
Crasson, M., Kjiri, S., Colin, A., Kjiri, K., L'Hermitte-Balériaux, M., Ansseau, M., & Legros, J.-J. (2004). Serum melatonin and urinary 6-sulfatoxymelatonin in major depression. Psychoneuroendocrinology, 29, 1-12. doi:10.1016/S0306-4530(02)00123-3 Peer Reviewed verified by ORBi |
Hansenne, M., Laloyaux, O., Mardaga, S., & Ansseau, M. (2004). Impact of low frequency transcranial magnetic stimulation on event-related brain potentials. Biological Psychology, 67 (3), 331-41. doi:10.1016/j.biopsycho.2004.01.004 Peer Reviewed verified by ORBi |
Masson, A.-M., Hoyois, P., Cadot, M., Nahama, V., Petit, F., & ANSSEAU, M. (2004). Les filles réussissent mieux que les garçons a l'université: Étude et modélisation des facteurs relatifs à la motivation et à l'agressivité mis en jeu lors des épreuves. Encéphale (L'), 30 (1), 1-15. doi:10.1016/s0013-7006(04)95410-3 Peer Reviewed verified by ORBi |
Ansseau, M. (2004). Evaluation des paramètres d'activité de gélules d'extrait sec de passiflore selon un modele "en étoile". Journal de Pharmacie de Belgique, 59 (4), 97-99. Peer Reviewed verified by ORBi |
Ansseau, M., Dierick, M., Buntinkx, F., Cnockaert, P., De Smedt, J., Van Den Haute, M., & Vander Mijnsbrugge, D. (2004). High prevalence of mental disorders in primary care. Journal of Affective Disorders, 78 (1), 49-55. doi:10.1016/s0165-0327(02)00219-7 Peer Reviewed verified by ORBi |
Charlier, C., Broly, F., Pinto, E., Ansseau, M., Plomteux, G., & Lhermitte, M. (December 2003). Polymorphisms in the CYP 2D6 gene: Association with plasma concentrations of fluoxetine and paroxetine. Therapeutic Drug Monitoring, 25 (6), 738-742. doi:10.1097/00007691-200312000-00014 Peer Reviewed verified by ORBi |
Tortolani, I., Scantamburlo, G., Ansseau, M., & Legros, J.-J. (October 2003). Exposition hormonale precoce et repercussions comportementales dans l'hyperplasie congenitale des surrenales: a propos d'un cas. Revue Médicale de Liège, 58 (10), 631-4. Peer reviewed |
Mignon, A., Fischler, B., Ansseau, M., Dierick, M., & Leyman, S. (September 2003). Generalized anxiety and major depression in a Belgian primary care setting, influence by socio-economic factors. The GADIS II study. European Neuropsychopharmacology, 13 (Suppl. 4), 368. Peer Reviewed verified by ORBi |
Papart, P., Liota, F., Bartholomé, F., & Ansseau, M. (September 2003). Cognitive topography imbalance in alcoholism. Journal of Psychophysiology, 17 (Suppl 1), 7-8. Peer reviewed |
Pinto, E., Reggers, J., Hansenne, M., Pitchot, W., Fuchs, S., Gorwood, P., Vaira, D., & Ansseau, M. (September 2003). Relationships between DRD2 and DAT polymorphisms and personality traits in healthy subjects. European Neuropsychopharmacology, 13 (Suppl. 4), 427-S428. doi:10.1016/S0924-977X(03)92300-5 Peer Reviewed verified by ORBi |
De Witte, P., Pinto, E., Ansseau, M., & Verbanck, P. (May 2003). Alcohol and withdrawal: from animal research to clinical issues. Neuroscience and Biobehavioral Reviews, 27 (3), 189-197. doi:10.1016/S0149-7634(03)00030-7 Peer Reviewed verified by ORBi |
Lorant, V., Deliege, D., Eaton, W., Robert, A., Philippot, P., & Ansseau, M. (15 January 2003). Socioeconomic inequalities in depression: A meta-analysis [letter to the editor]. American Journal of Epidemiology, 157 (2), 98-112. doi:10.1093/aje/kwf182 Peer Reviewed verified by ORBi |
Hansenne, M., Pinto, E., Scantamburlo, G., Renard, B., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Harm avoidance is related to mismatch negativity (MMN) amplitude in healthy subjects. Personality and Individual Differences, 34 (6), 1039-1048. doi:10.1016/S0191-8869(02)00088-0 Peer Reviewed verified by ORBi |
Pitchot, W., Reggers, J., Pinto, E., Hansenne, M., & Ansseau, M. (2003). Catecholamine and HPA axis dysfunction in depression : relationship with suicidal behavior. Neuropsychobiology, 47 (3), 152-157. doi:10.1159/000070585 Peer Reviewed verified by ORBi |
Couvreur, A., Cleinge, L., Wauthy, J., Vaulet, V., Meeremans, C., Tacconi, G., Debaere, T., Ansseau, M., & Pitchot, W. (2003). Le fonctionnement en réseau : une nouvelle vision de soins en santé mentale. Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles, (5), 59-67. Peer reviewed |
Hansenne, M., Olin, C., Pinto, E., Pitchot, W., & Ansseau, M. (2003). Event-related potentials to emotional and neutral stimuli in alcoholism. Neuropsychobiology, 48 (2), 77-81. doi:10.1159/000072881 Peer Reviewed verified by ORBi |
Colin, A., Reggers, J., Castronovo, V., & Ansseau, M. (2003). Lipides, dépression et suicide. Encéphale (L'), 29 (1, JAN-FEB), 49-58. Peer Reviewed verified by ORBi |
Pinto, E., Reggers, J., Fuchs, S., Venneman, I., Lamy, M., & Ansseau, M. (2003). Toxicomanes: sevrage ultrarapide aux opiacés sous anesthésie générale au CHU de Liège. Agenda Psychiatrie, 28, 1-2. Peer reviewed |
Lorant, V., Kampfl, D., Seghers, A., Deliege, D., Closon, M. C., & Ansseau, M. (2003). Socio-economic differences in psychiatric in-patient care. Acta Psychiatrica Scandinavica, 107 (3), 170-177. doi:10.1034/j.1600-0447.2003.00071.x Peer Reviewed verified by ORBi |
Masson, A.-M., Cadot, M., & Ansseau, M. (2003). Perfectionnisme: Effets du sexe et de l'echec. Encéphale (L'), 29 (2), 125-135. Peer Reviewed verified by ORBi |
Hansenne, M., Pinto, E., Scantamburlo, G., Couvreur, A., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Mismatch negativity is not correlated with neuroendocrine indicators of catecholaminergic activity in healthy subjects. Human Psychopharmacology, 18 (3), 201-5. doi:10.1002/hup.468 Peer Reviewed verified by ORBi |
PAQUAY, C., PITCHOT, W., Reggers, J., & ANSSEAU, M. (2003). Dépression, anxiété, agressivité, impulsivité et comportement suicidaire. Acta Psychiatrica Belgica, 103, 161-170. Peer Reviewed verified by ORBi |
Charlier, C., Pinto, E., Ansseau, M., & Plomteux, G. (December 2002). Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients. Journal of Psychopharmacology, 16 (4), 369-372. doi:10.1177/026988110201600413 Peer Reviewed verified by ORBi |
Pitchot, W., Wauthy, J., Hansenne, M., Pinto, E., Fuchs, S., Reggers, J., Legros, J.-J., & Ansseau, M. (October 2002). Hormonal and temperature responses to the 5-HT1a receptor agonist flesinoxan in normal volunteers. Psychopharmacology, 164 (1), 27-32. doi:10.1007/s00213-002-1177-0 Peer Reviewed verified by ORBi |
Michel, A., Ansseau, M., Legros, J.-J., Pitchot, W., & Mormont, C. (October 2002). The transsexual : what about the future ? European Psychiatry, 17 (6), 353-362. doi:10.1016/S0924-9338(02)00703-4 Peer Reviewed verified by ORBi |
Dierick, M., De Nayer, A., Ansseau, M., D'Haenen, H., Cosyns, P., Verbruggen, W., Seghers, A., Pelc, I., Fossion, P., Stefos, G., Peuskens, J., Malfroid, M., Leyman, S., & Mignon, A. (August 2002). An eight-week, open-label, uncontrolled, multicenter, phase IV study of remission rates in outpatients and inpatients with major depression treated with venlafaxine. Current Therapeutic Research, 63 (8), 475-485. doi:10.1016/s0011-393x(02)80053-4 Peer Reviewed verified by ORBi |
Michel, A., Ansseau, M., Legros, J.-J., Pitchot, W., Cornet, J.-P., & Mormont, C. (August 2002). Comparisons of two groups of sex-change applicants based on the MMPI. Psychological Reports, 91 (1), 233-240. doi:10.2466/pr0.2002.91.1.233 Peer Reviewed verified by ORBi |
Scantamburlo, G., Fuchs, S., Lancellotti, P., & Ansseau, M. (May 2002). Troubles anxieux et pathologies organiques: un diagnostic differentiel difficile. Revue Médicale de Liège, 57 (5), 303-306. Peer reviewed |
Pinto, E., Reggers, J., PITCHOT, W., Hansenne, M., Fuchs, S., & Ansseau, M. (2002). Neuroendocrine evaluation of 5-HT1A function in male alcoholic patients. Psychoneuroendocrinology, 27 (7), 873-879. doi:10.1016/S0306-4530(01)00088-9 Peer Reviewed verified by ORBi |
Kebers, F., Janvier, S., Colin, A., Legros, J.-J., & Ansseau, M. (2002). En quoi le syndrome de Klinefelter peut-il interesser le psychiatre et le pedopsychiatre? Encéphale (L'), 28 (3), 260-265. Peer Reviewed verified by ORBi |
Hansenne, M., Pinto, E., Pitchot, W., Reggers, J., Scantamburlo, G., Moor, M., & Ansseau, M. (2002). Further evidence on the relationship between dopamine and novelty seeking: a neuroendocrine study. Personality and Individual Differences, 33 (6), 967-977. doi:10.1016/S0191-8869(01)00205-7 Peer Reviewed verified by ORBi |
Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Scantamburlo, G., Fuchs, S., Pirard, S., & Ansseau, M. (2002). 5-HT1A dysfunction in borderline personality disorder. Psychological Medicine, 32 (5), 935-41. doi:10.1017/S0033291702005445 Peer Reviewed verified by ORBi |
Hansenne, M., Pitchot, W., & Ansseau, M. (2002). Serotonin, personality and borderline personality disorder. Acta Neuropsychiatrica, 14 (2), 66-70. doi:10.1034/j.1601-5215.2002.140203.x Peer Reviewed verified by ORBi |
ANSSEAU, M. (2002). Serotonergic Antidepressants in Obsessive-Compulsive Personality Disorder. In M. Maj, Obsessive-Compulsive Disorder (Second Edition) (pp. 89-91). Chichester, United States - New Jersey: Wiley Blackwell. doi:10.1002/0470861657.ch2 Peer reviewed |
Triffaux, J.-M., Wauthy, J., Albert, A., Bertrand, J.-M., Limet, R., Demoulin, J.-C., Dozot, J.-P., & Ansseau, M. (December 2001). Psychological distress of surgical patients after orthotopic heart transplantation. Transplant International, 14 (6), 391-395. doi:10.1007/s001470100004 Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., & Ansseau, M. (November 2001). Role of dopamine in non-depressed patients with a history of suicide attempts. European Psychiatry, 16 (7), 424-427. doi:10.1016/S0924-9338(01)00601-0 Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., Gonzalez Moreno, A., Pinto, E., Reggers, J., Fuchs, S., Pirard, S., & Ansseau, M. (October 2001). Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality. Psychoneuroendocrinology, 26 (7), 689-696. doi:10.1016/S0306-4530(01)00021-X Peer Reviewed verified by ORBi |
Triffaux, J.-M., Wauthy, J., Bertrand, J.-M., Limet, R., Albert, A., & Ansseau, M. (April 2001). Psychological Evolution and Assessment in Patients Undergoing Orthotopic Heart Transplantation. European Psychiatry, 16 (3), 180-5. doi:10.1016/S0924-9338(01)00561-2 Peer Reviewed verified by ORBi |
PITCHOT, W., Reggers, J., Pinto, E., Hansenne, M., Fuchs, S., Pirard, S., & Ansseau, M. (April 2001). Reduced dopaminergic activity in depressed suicides. Psychoneuroendocrinology, 26 (3), 331-335. doi:10.1016/S0306-4530(00)00047-0 Peer Reviewed verified by ORBi |
Scantamburlo, G., Ansseau, M., & Legros, J.-J. (2001). Implication de la neurohypophyse dans le stress psychique. Encéphale (L'), 27 (3, May-Jun), 245-59. Peer Reviewed verified by ORBi |
Hansenne, M., Le Bon, O., Gauthier, A., & Ansseau, M. (2001). Belgian normative data of the temperament and character inventory. European Journal of Psychological Assessment, 17 (1), 56-62. doi:10.1027//1015-5759.17.1.56 Peer reviewed |
PITCHOT, W., & ANSSEAU, M. (2001). Venlafaxine induced hair loss. American Journal of Psychiatry. doi:10.1176/appi.ajp.158.7.1159-a Peer Reviewed verified by ORBi |
Masson, A.-M., Cadot, M., Pereira, A. M., Depreeuw, E., & Ansseau, M. (2001). Version francophone du TASTE (test for ability to study and evaluation). Encéphale (L'), 27 (6), 527-538. Peer Reviewed verified by ORBi |
Lepine, J. P., Altamura, C., ANSSEAU, M., Ayuso Gutierrez, J. L., Bitter, I., Lader, M., & Waintraub, L. (2001). Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: An international, 6-week double-blind study. Human Psychopharmacology, 16 (3), 219-227. doi:10.1002/hup.289 Peer Reviewed verified by ORBi |
Mancuso, G., Lejeune, M., & Ansseau, M. (2001). Cigarette Smoking and Attention: Processing Speed or Specific Effects? Psychopharmacology, 155 (4), 372-378. doi:10.1007/s002130000678 Peer Reviewed verified by ORBi |
David, C., WAUTHY, J., Vaulet, V., Frognet, E., Franck, N., PITCHOT, W., & ANSSEAU, M. (2001). Le médicament parmi les thérapies relationnelles : Enquête et réflexions. Revue des Hôpitaux de Jour Psychiatriques et des Thérapies Institutionnelles. Peer reviewed |
PITCHOT, W., & ANSSEAU, M. (2001). Reply to Letter to the Editor. Psychoneuroendocrinology. Peer Reviewed verified by ORBi |
Pitchot, W., Herrera, C., & Ansseau, M. (2001). Hpa Axis Dysfunction in Major Depression: Relationship to 5-Ht(1a) Receptor Activity. Neuropsychobiology, 44 (2), 74-7. doi:10.1159/000054919 Peer Reviewed verified by ORBi |
Allouch, A., Bruwier, M., Comte-Tassin, M., ANDRIANNE, R., Colin, A., Kjiri, K., Reginster, J.-Y., de Leval, L., Ansseau, M., & Legros, J.-J. (2001). Incidence des perturbations psychoendocriniennes au centre interdisciplinaire de l’andropause (CIA) du CHU de Liège : bilan des 7 premiers mois d’activité. Annales d'Endocrinologie, 62 (4), 178. Peer Reviewed verified by ORBi |
PITCHOT, W., & ANSSEAU, M. (2001). Adding olanzapine to venlafaxine in treatment-refractory non-psychotic chronic depression. American Journal of Psychiatry. Peer Reviewed verified by ORBi |
Mormont, C., & ANSSEAU, M. (2001). Anorexie. In M. Crahay & C. Goffinet (Eds.), Regards croisés sur l’anorexie (pp. 11-14). Liège, Belgium: ULg - Université de Liège. |
Hansenne, M., & Ansseau, M. (2001). Contingent negative variation and personality in depression. Neuropsychobiology, 44 (1), 7-12. doi:10.1159/000054907 Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2001). Alpha-2-adrenoreceptors in depressed suicide attempters : relationship with medical lethality of the attempt. Neuropsychobiology, 44 (2), 91-94. doi:10.1159/000054923 Peer Reviewed verified by ORBi |
Guelfi, J. D., ANSSEAU, M., Timmerman, L., Kørsgaard, S., & The Mirtazapine-Venlafaxine Study Group. (2001). Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features. Journal of Clinical Psychopharmacology, 21 (4), 425-431. doi:10.1097/00004714-200108000-00010 Peer Reviewed verified by ORBi |
Lôo, H., Saiz-Ruiz, J., Costa E Silva, J. A., ANSSEAU, M., Herrington, R., Vaz-Serra, A., Dilling, H., & De Risio, S. (2001). Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. Human Psychopharmacology, 16 (Suppl. 1), 31-S38. doi:10.1002/hup.268 Peer Reviewed verified by ORBi |
Pinto, E., Reggers, J., Delhez, M., Fuchs, S., Venneman, I., Lamy, M., & Ansseau, M. (2001). Le sevrage ultra-rapide des toxicomanes aux opiaces sous anesthésie générale: resultats préliminaires du protocole liégeois. Revue Médicale de Liège, 56 (8), 572-576. Peer reviewed |
Pinto, E., Reggers, J., Delhez, M., Fuchs, S., VENNEMAN, I., Lamy, M., & ANSSEAU, M. (2001). Le sevrage ultra-rapide des toxicomanes aux opiaciés sous anesthiésie géniérale: Résultats préliminaires du protocole Liègeois. Revue Médicale de Liège, 56 (8), 572-576. Peer reviewed |
Dalem, I., Piccinin, B., Lerminiaux, D., & Ansseau, M. (December 2000). L'anorexie mentale du garcon. Revue Médicale de Liège, 55 (12), 1051-1057. Peer reviewed |
Charlier, C., Pinto, E., Ansseau, M., & Plomteux, G. (August 2000). Relationship between Clinical Effects, Serum Drug Concentration, and Concurrent Drug Interactions in Depressed Patients Treated with Citalopram, Fluoxetine, Clomipramine, Paroxetine or Venlafaxine. Human Psychopharmacology, 15 (6), 453-459. doi:10.1002/1099-1077(200008)15:6<453::AID-HUP228>3.0.CO;2-F Peer Reviewed verified by ORBi |
Dandrifosse, A. C., & Ansseau, M. (May 2000). Recommandations dans le traitement des troubles anxieux chez l'adulte. Revue Médicale de Liège, 55 (5), 400-408. Peer reviewed |
Reggers, J., & Ansseau, M. (May 2000). Recommandations dans le traitement des toxicomanies aux opiacés. Revue Médicale de Liège, 55 (5), 409-416. Peer reviewed |
Fuchs, S., Reggers, J., & Ansseau, M. (May 2000). Recommandations dans le traitement de la dépression. Revue Médicale de Liège, 55 (5), 389-394. Peer reviewed |
Triffaux, J.-M., Wauthy, J., Albert, A., Bertrand, J., Limet, R., demoulin, J.-C., dozot, J.-P., & Ansseau, M. (2000). Effect of psychological intervention on psychopathology after heart transplantation [Poster presentation]. XXII C.I.N.P Congres, Bruxelles, Belgium. |
Hansenne, M., Pitchot, W., Pinto, E., Papart, P., & Ansseau, M. (2000). Serotonergic-1a activity and contingent negative variation. Biological Psychology, 52 (3), 259-65. doi:10.1016/S0301-0511(99)00047-2 Peer Reviewed verified by ORBi |
Papart, P., WEERTS, P., Pinto, E., Hansenne, M., & Ansseau, M. (2000). Relationship between CNV topography and irritability in depression. Journal of Psychophysiology, 14 (Suppl 1). Peer reviewed |
Ansseau, M., Besson, J., Lejoyeux, M., Pinto, E., Landry, U., Cornes, M., Deckers, F., Potgieter, A., & Ades, J. (2000). A French translation of the obsessive-compulsive drinking scale for craving in alcohol-dependent patients: A validation study in Belgium, France, and Switzerland. European Addiction Research, 6 (2), 51-6. doi:10.1159/000019010 Peer Reviewed verified by ORBi |
Ajamieh, A., & Ansseau, M. (2000). Les marqueurs biologiques dans les personnalites schizotypique et borderline. Encéphale (L'), 26 (6), 42-54. Peer Reviewed verified by ORBi |
Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Papart, P., & Ansseau, M. (2000). P300 event-related brain potential and personality in depression. European Psychiatry, 15 (6), 370-7. doi:10.1016/S0924-9338(00)00505-8 Peer Reviewed verified by ORBi |
Calvisi, V., & Ansseau, M. (December 1999). Le cas clinique du mois. Confusion mentale liée à l'administration de tramadol chez une patiente sous IMAO. Revue Médicale de Liège, 54 (12), 912-913. Peer reviewed |
Coton, X., Ansseau, M., Parent, M.-T., Jadot, M., & Ernotte, D. (September 1999). Un cas de myasthenie diagnostiquee trouble de conversion. Revue Médicale de Liège, 54 (9), 722-724. Peer reviewed |
Ansseau, M. (August 1999). Pharma-clinics. Le medicament du mois. Le zaleplon (Sonataρ). Revue Médicale de Liège, 54 (8), 705-6. Peer reviewed |
Reggers, J., & Ansseau, M. (April 1999). Les phobies spécifiques chez la femme. Revue Médicale de Liège, 54 (4), 329-334. Peer reviewed |
Vanturenhout, C., & Ansseau, M. (April 1999). La dépression chez la femme. Revue Médicale de Liège, 54 (4), 322-328. Peer reviewed |
Charlier, C., Ansseau, M., Pinto, E., Andrien, F., & Plomteux, G. (1999). Le controle thérapeutique des médicaments antidépresseurs. Annales de Biologie Clinique, 57 (4, Jul-Aug), 463-8. Peer Reviewed verified by ORBi |
Hansenne, M., & Ansseau, M. (1999). P300 event-related potential and serotonin-1A activity in depression. European Psychiatry, 14 (3), 143-7. doi:10.1016/S0924-9338(99)80732-9 Peer Reviewed verified by ORBi |
Hansenne, M., & Ansseau, M. (1999). Harm avoidance and serotonin. Biological Psychology, 51 (1), 77-81. doi:10.1016/S0301-0511(99)00018-6 Peer Reviewed verified by ORBi |
Lôo, H., Saiz-Ruiz, J., Costa E Silva, J. A., ANSSEAU, M., Herrington, R., Vaz-Serra, A., Dilling, H., & De Risio, S. (1999). Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. Journal of Affective Disorders, 56 (2-3), 109-118. doi:10.1016/S0165-0327(99)00009-9 Peer Reviewed verified by ORBi |
Mancuso, G., Andrès Bénito, P., Ansseau, M., & Tirelli, E. (1999). Effects on nicotine administered via a transdermal delivery system on vigilance : a repeated measure study. Psychopharmacology, 142 (1), 18-23. doi:10.1007/s002130050857 Peer Reviewed verified by ORBi |
Reginster, J.-Y., Deroisy, R., Paul, I., Hansenne, M., & Ansseau, M. (1999). Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women. Maturitas, 33 (2), 133-7. doi:10.1016/S0378-5122(99)00057-2 Peer Reviewed verified by ORBi |
Coton, X., ANSSEAU, M., Parent, M., Jadot, M., & Ernotte, D. (1999). Le cas clinique du mois un cas de myasthénie diagnostiquée trouble de conversion. Revue Médicale de Liège, 54 (9), 722-724. Peer reviewed |
Hansenne, M., Reggers, J., Pinto, E., Kjiri, K., Ajamier, A., & Ansseau, M. (1999). Temperament and character inventory (TCI) and depression. Journal of Psychiatric Research, 33 (1), 31-6. doi:10.1016/S0022-3956(98)00036-3 Peer Reviewed verified by ORBi |
Ansseau, M. (May 1998). Socio-économie de la dépression. Revue Médicale de Liège, 53 (5), 308-310. Peer reviewed |
Ansseau, M. (February 1998). Pharma-clinics. Le médicament du mois. La venlafaxine (Efexor). Revue Médicale de Liège, 53 (2), 106-108. Peer reviewed |
Guelfi, J. D., ANSSEAU, M., Corruble, E., Samuelian, J. C., Tonelli, I., Tournoux, A., & Plétan, Y. (1998). A double-blind comparison of the efficacy and safety of milnacipran and fluoxetine in depressed inpatients. International Clinical Psychopharmacology, 13 (3), 121-128. doi:10.1097/00004850-199805000-00005 Peer Reviewed verified by ORBi |
ANSSEAU, M., & PITCHOT, W. (1998). Dépression et suicide : Aspects biologiques. Neuro-psy. Peer reviewed |
Hansenne, M., & Ansseau, M. (1998). Catecholaminergic function and temperament in major depressive disorder: a negative report. Psychoneuroendocrinology, 23 (5), 477-83. doi:10.1016/S0306-4530(98)00021-3 Peer Reviewed verified by ORBi |
Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Machurot, P. Y., & Ansseau, M. (1998). The tridimensional personality questionnaire (TPQ) and depression. European Psychiatry, 13 (2), 101-3. doi:10.1016/S0924-9338(98)80026-6 Peer Reviewed verified by ORBi |
Kjiri, K., Ajamieh, A., Hansenne, M., & ANSSEAU, M. (1998). Un cas de syndrome de Munchausen (trouble factice). Revue Médicale de Liège, 53 (7), 390-392. Peer reviewed |
Kjiri, K., Ajamieh, A., Hansenne, M., & Ansseau, M. (1998). Le cas clinique du mois. Un cas de syndrome de Munchausen (trouble factice). Revue Médicale de Liège, 53 (7), 390-2. Peer reviewed |
Hansenne, M., PITCHOT, W., Papart, P., & ANSSEAU, M. (1998). Serotonergic modulation of the P300 event related brain potential. Human Psychopharmacology, 13 (4), 239-243. doi:10.1002/(SICI)1099-1077(199806)13:4<239::AID-HUP986>3.0.CO;2-V Peer Reviewed verified by ORBi |
Abraini, J. H., ANSSEAU, M., Bisson, T., Juan De Mendoza, J.-L., & Therme, P. (1998). Personality patterns of anxiety during occupational deep dives with long-term confinement in hyperbaric chamber. Journal of Clinical Psychology, 54 (6), 825-830. doi:10.1002/(SICI)1097-4679(199810)54:6<825::AID-JCLP10>3.0.CO;2-N Peer Reviewed verified by ORBi |
Ansseau, M. (01 November 1997). Dépressions brèves récurrentes. Revue du Praticien, 47 (17), 1904-1906. Peer reviewed |
Charlier, C., Ansseau, M., Gougnard, T., Andrien, F., & Plomteux, G. (May 1997). Le monitoring thérapeutique des antidépresseurs. Revue Médicale de Liège, 52 (5), 336-44. Peer reviewed |
Ansseau, M. (April 1997). La dépression de la personne âgée. Revue Médicale de Liège, 52 (4), 262-266. Peer reviewed |
Hansenne, M., Pitchot, W., Moreno, A. G., Reggers, J., Machurot, P.-Y., & Ansseau, M. (1997). Harm avoidance dimension of the Tridimensional Personality Questionnaire and serotonin-1A activity in depressed patients. Biological Psychiatry, 42 (10), 959-61. doi:10.1016/S0006-3223(97)00325-9 Peer Reviewed verified by ORBi |
Papart, P., Ansseau, M., & Timsit-Berthier, M. (1997). Influence of Diazepam on Contingent Negative Variation. Human Psychopharmacology, 12, 95-98. doi:10.1002/(SICI)1099-1077(199703/04)12:2<95::AID-HUP841>3.0.CO;2-3 Peer Reviewed verified by ORBi |
Charlier, C., Ansseau, M., Pinto, E., Andrien, F., & Plomteux, G. (1997). Manifestations indésirables des antidépresseurs. Toxicorama, (Spécial LYON), 310-314. Peer reviewed |
Ramaekers, J. G., ANSSEAU, M., Muntjewerff, N. D., Sweens, J. P., & O'Hanlon, J. F. (1997). Considering the P450 cytochrome system as determining combined effects of antidepressants and benzodiazepines on actual driving performance of depressed outpatients. International Clinical Psychopharmacology, 12 (3), 159-169. doi:10.1097/00004850-199705000-00007 Peer Reviewed verified by ORBi |
Ansseau, M. (October 1996). Pharma-clinics. Le médicament du mois. La risperidone (Risperdal). Revue Médicale de Liège, 51 (10), 665-667. Peer reviewed |
Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Zaldua, I. U., & Ansseau, M. (1996). Suicidal behavior in depressive disorder: an event-related potential study. Biological Psychiatry, 40 (2), 116-22. doi:10.1016/0006-3223(95)00372-X Peer Reviewed verified by ORBi |
ANSSEAU, M., Bataille, M., Briole, G., De Nayer, A., Fauchère, P. A., Ferrero, F., Mertens, C., Realini, R., Rombaut, P., Vereecken, A., Troisfontaines, B., & Van Moffaert, M. (1996). Controlled comparison of tianeptine, alprazolam and mianserin in the treatment of adjustment disorders with anxiety and depression. Human Psychopharmacology, 11 (4), 293-298. doi:10.1002/(SICI)1099-1077(199607)11:4<293::AID-HUP771>3.0.CO;2-Z Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., Moreno, A. G., & Ansseau, M. (1996). Growth hormone response to apomorphine in obsessive-compulsive disorder. Journal of Psychiatry and Neuroscience, 21 (5), 343-5. Peer Reviewed verified by ORBi |
Ansseau, M. (January 1996). Les antidépresseurs. Revue Médicale de Liège, 51 (1), 78-84. Peer reviewed |
Ansseau, M. (1996). Les benzodiazépines. Revue Médicale de Liège, 51 (1), 70-77. Peer reviewed |
Papart, P., Ansseau, M., & Timsit-Berthier, M. (1996). CNV in mood disorders. In Recent advances in event-related brain potential research (pp. 897-900). Elsevier Science. Peer reviewed |
ANSSEAU, M. (1996). Pharma-clinics, le médicament du mois : La rispéridone (Risperdal®). Revue Médicale de Liège, 51 (10), 665-667. Peer reviewed |
Pitchot, W., & Ansseau, M. (November 1995). Le cas clinique du mois. Dépression majeure chez un patient diabétique. Revue Médicale de Liège, 50 (11), 451-452. Peer reviewed |
Fontaine, P., & ANSSEAU, M. (1995). Aspects pharmaco-cliniques de la méthadone : Revue de la littérature sur son intérêt dans le traitement des toxicomanies. Encéphale (L'), 21 (3), 167-179. Peer Reviewed verified by ORBi |
Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Lembreghts, M., Hansenne, M., Wauthy, J., Reel, C., Jammaer, R., Papart, P., Sulon, J., & Legros, J.-J. (1995). The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry, 28 (Suppl. 2), 91-92. doi:10.1055/s-2007-979625 Peer Reviewed verified by ORBi |
Urcelay-Zaldua, I., Hansenne, M., & Ansseau, M. (1995). Influence du risque suicidaire et du desespoir sur l'amplitude de l'onde P300 dans la depression majeure. Neurophysiologie Clinique, 25 (5), 291-296. doi:10.1016/0987-7053(96)80172-9 Peer Reviewed verified by ORBi |
Pichot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). Growth hormone response to apomorphine in panic disorder: comparison with major depression and normal controls. European Archives of Psychiatry and Clinical Neuroscience, 245 (6), 306-308. doi:10.1007/BF02191872 Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). Growth hormone response to clonidine in nondepressed patients with a history of suicide attempts. Biological Psychiatry, 38 (3), 201-203. doi:10.1016/0006-3223(95)00147-9 Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). The dexamethasone suppression test in violent suicide attempters with major depression. Biological Psychiatry, 37 (4), 273-274. doi:10.1016/0006-3223(94)00228-U Peer Reviewed verified by ORBi |
Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Papart, P., Timsit-Berthier, M., & Ansseau, M. (1995). Catecholaminergic function and P300 amplitude in major depressive disorder (P300 and catecholamines). Electroencephalography and Clinical Neurophysiology, 96 (2), 194-196. doi:10.1016/0168-5597(94)00317-8 Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1995). Effect of previous antidepressant therapy on the growth hormone response to apomorphine. Neuropsychobiology, 32 (1), 19-22. doi:10.1159/000119207 Peer Reviewed verified by ORBi |
Pitchot, W., Ansseau, M., Gonzalez Moreno, A., & Hansenne, M. (1995). Responses to mCPP stimulation in depressed patients. American Journal of Psychiatry, 152 (12), 1834; author reply 1834-5. doi:10.1176/ajp.152.12.1834 Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., Gonzalez Moreno, A., Wauthy, J., & Ansseau, M. (1995). Bases biologiques du comportement suicidaire: approche neuroendocrinienne et psychophysiologique du role des catecholamines. Acta Psychiatrica Belgica, 95 (4-5), 210-233. Peer Reviewed verified by ORBi |
Charles, G., Hansenne, M., Ansseau, M., Pitchot, W., Machowski, R., Schittecatte, M., & Wilmotte, J. (1995). P300 in posttraumatic stress disorder. Neuropsychobiology, 32 (2), 72-74. doi:10.1159/000119216 Peer Reviewed verified by ORBi |
Ansseau, M. (01 December 1994). Comment je traite... Un trouble de l'adaptation avec anxiété. Revue Médicale de Liège, 49 (12), 643-644. Peer reviewed |
Ansseau, M. (01 November 1994). Comment je traite...un premier épisode dépressif. Revue Médicale de Liège, 49 (11), 591-592. Peer reviewed |
Ansseau, M., Orban, P., Lecoq, A., De Nayer, A. R., Evrard, J.-L., Kremer, P., Devoitille, J.-M., Dierick, M., Mertens, C., Mesotten, F., Mirel, J., Troisfontaines, B., van Moffaert, M., & Vanbrabant, E. (June 1994). Controlled Comparison of Nefazodone and Amitriptyline in Major Depressive Inpatients. Psychopharmacology, 115 (1-2), 254-60. doi:10.1007/BF02244780 Peer Reviewed verified by ORBi |
Ansseau, M., Papart, P., Troisfontaines, B., Bartholome, F., Bataille, M., Charles, G., Schittecatte, M., Darimont, P., Devoitille, J. M., & De Wilde, J. (February 1994). Controlled Comparison of Milnacipran and Fluoxetine in Major Depression. Psychopharmacology, 114 (1), 131-7. doi:10.1007/BF02245454 Peer Reviewed verified by ORBi |
Ansseau, M., PITCHOT, W., Hansenne, M., WAUTHY, J., Moreno, A. G., Jammaer, R., Réel, C., Lembreghts, M., Papart, P., Gros-Gean, J., Devroye, A., Sulon, J., & Legros, J.-J. (1994). The flesinoxan/5-HT1A receptor challenge and suicidal behavior. European Neuropsychopharmacology, 4 (3), 322-323. doi:10.1016/0924-977X(94)90138-4 Peer Reviewed verified by ORBi |
ANSSEAU, M. (1994). Are SSRIs useful in obsessive-compulsive personality disorder? European Neuropsychopharmacology, 4 (3), 266-267. doi:10.1016/0924-977X(94)90085-X Peer Reviewed verified by ORBi |
ANSSEAU, M. (1994). Placebo-controlled study of clomipramine in panic patients taking benzodiazepines. European Neuropsychopharmacology, 4 (3), 356. doi:10.1016/0924-977X(94)90178-3 Peer Reviewed verified by ORBi |
ANSSEAU, M., PITCHOT, W., Wauthy, J., Moreno, A. G., Hansenne, M., Lembreghts, M., Jammaer, R., Réel, C., Gros-Gean, J., Sulon, J., & Legros, J.-J. (1994). The flesinoxan/5-HT1A receptor challenge in major depression. European Neuropsychopharmacology, 4 (3), 321-322. doi:10.1016/0924-977X(94)90137-6 Peer Reviewed verified by ORBi |
Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Wauthy, J., Hansenne, M., & von Frenckell, R. (1994). Relationship between alpha 2-adrenergic function and suicidal behavior in depressed patients. Psychiatry Research, 52 (2), 115-123. doi:10.1016/0165-1781(94)90081-7 Peer Reviewed verified by ORBi |
ANSSEAU, M. (1994). In memoriam Daniel Bobon. Revue Médicale de Liège, 49 (10), 531-533. Peer reviewed |
Lucchesi, L. M., Fernandes, M. H., Silva Junior, N., Yazigi, L., ANSSEAU, M., & Timsit-Berthier, M. (1994). Transcultural approach of depression. Comparative study of the diagnostic performance of the dexamethasone suppression test in Sao Paulo (Brazil) and Liege (Belgium). European Psychiatry, 9 (4), 195-200. Peer Reviewed verified by ORBi |
ANSSEAU, M., PITCHOT, W., & Gonzalez Moreno, A. (1994). Anxiolytic activity of single doses of the 5-HT3 antagonist zacopride. European Neuropsychopharmacology, 4 (3), 355. doi:10.1016/0924-977X(94)90177-5 Peer Reviewed verified by ORBi |
ANSSEAU, M. (1994). Depression, 5‐HT deficit, SSRIs…and tianeptine. Human Psychopharmacology, 9 (6), 391-392. doi:10.1002/hup.470090601 Peer Reviewed verified by ORBi |
Petit, N., Delporte, J.-P., ANSSEAU, M., Albert, A., & Jeusette, F. (1994). Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital. Pharmacy World and Science, 16 (4), 181-186. doi:10.1007/BF01872866 Peer Reviewed verified by ORBi |
Triffaux, J.-M., Bertrand, M., ANSSEAU, M., Limet, R., & Kulbertus, H. (1994). Evaluation et accompagnement psychologique au cours de la transplantation cardiaque. Psychologie Médicale, 26 (2), 175-179. Peer reviewed |
Hansenne, M., Pitchot, W., Gonzalez Moreno, A., Gonzalez Torrecilas, J., Mirel, J., & Ansseau, M. (1994). Psychophysiological correlates of suicidal behavior in depression. A preliminary study. Neuropsychobiology, 30 (1), 1-3. doi:10.1159/000119125 Peer Reviewed verified by ORBi |
Triffaux, J.-M., Bertrand, J., Ansseau, M., Limet, R., & Kulbertus, H. (1994). Evaluation et accompagnement psychologique du patient au cours de la transplantation cardiaque. Psychologie Médicale, 26 (Spéc. 2), 175-179. Peer reviewed |
WAUTHY, J., Mormont, C., & Ansseau, M. (1994). Troubles mnésiques et éléments de "psychopathologie" chez des patients déprimés majeurs. Acta Psychiatrica Belgica, 94 (1), 58-9. Peer Reviewed verified by ORBi |
ANSSEAU, M., Gabriëls, A., Loyens, J., Bartholomé, F., Evrard, J. L., De Nayer, A., Linhart, R., Wirtz, J., Bruynooghe, F., Surinx, K., Clarysse, H., Marganne, R., & Papart, P. (1994). Controlled comparison of paroxetine and fluvoxamine in major depression. Human Psychopharmacology, 9 (5), 329-336. doi:10.1002/hup.470090502 Peer Reviewed verified by ORBi |
Abraini, J. H., ANSSEAU, M., Martinez, E., Burner, H., Wauthy, J., & Lemaire, C. (1994). Development of anxiety symptoms during a deep diving experiment. Anxiety, 1 (5), 237-241. doi:10.1002/anxi.3070010509 Peer Reviewed verified by ORBi |
Schittecatte, M., Charles, G., Machowski, R., Dumont, F., Garcia-Valentin, J., Wilmotte, J., Papart, P., PITCHOT, W., WAUTHY, J., Ansseau, M., Pelc, I., & Hoffman, G. (1994). Effect of gender and diagnostic on growth hormone response to clonidine for major depression : A large scale multicenter study. American Journal of Psychiatry, 151 (2), 216-220. doi:10.1176/ajp.151.2.216 Peer Reviewed verified by ORBi |
Papart, P., ANSSEAU, M., & Timsit-Berthier, M. (1994). Contingent negative variation (CNV) in mood disorders. European Neuropsychopharmacology, 4 (3), 323. doi:10.1016/0924-977x(94)90139-2 Peer Reviewed verified by ORBi |
Abraini, J. H., Ansseau, M., & Fechtali, T. (01 November 1993). Pressure-Induced Disorders in Neurotransmission and Spontaneous Behavior in Rats: An Animal Model of Psychosis. Biological Psychiatry, 34 (9), 622-629. doi:10.1016/0006-3223(93)90154-6 Peer Reviewed verified by ORBi |
Ansseau, M. (August 1993). Critères cliniques d'évaluation de la guérison de la dépression. Aspects méthodologiques. Encéphale (L'), 19 (Spec No 3), 441-4. Peer Reviewed verified by ORBi |
ANSSEAU, M., Leboulle, D., Sulon, J., von Frenckell, R., & Legros, J.-J. (1993). Oral contraceptives and the dexamethasone suppression test. Psychoneuroendocrinology, 18 (1), 37-43. doi:10.1016/0306-4530(93)90053-N Peer Reviewed verified by ORBi |
ANSSEAU, M., Gabriëls, A., Loyens, J., Bartholomé, F., Evrard, J.-L., De Nayer, A. R., Linhart, R., Wirtz, J., Bruynoghe, F., Surinx, K., Clarysse, H., Marganne, R., & Papart, P. (1993). A double-blind comparison of paroxetine and fluvoxamine in major depression. European Neuropsychopharmacology, 3 (3), 323-324. doi:10.1016/0924-977x(93)90099-8 Peer Reviewed verified by ORBi |
Machurot, P.-Y., Hansenne, M., Pitchot, W., Gonzalez Moreno, A., & Ansseau, M. (1993). L'état de stress post-traumatique chez les brûlés : Une revue. Acta Psychiatrica Belgica, 93 Spec No, 359-367. Peer Reviewed verified by ORBi |
Hansenne, M., Charles, G., Pholien, P., Panzer, M., PITCHOT, W., & Ansseau, M. (1993). Mesure subjective de l'impact d'un événement : traduction française et adaptation de l'échelle d'Horowitz. Psychologie Médicale, 25 (1), 86-88. Peer reviewed |
Angst, J., ANSSEAU, M., Bech, P., Engel, R. R., Hippius, H., Lader, M., Lecrubier, Y., Lingjaerde, O., Paes de Sousa, M., Rossi, A., Ruther, E., Saletu, B., Stefanis, C. N., Stoll, K. D., Westenberg, H. G. M., & Woggon, B. (1993). Report on the Fourth Consensus Conference on the Methodology of Clinical Trials with Anxiolytic Drugs. Pharmacopsychiatry, 26 (1), 1-5. doi:10.1055/s-2007-1014332 Peer Reviewed verified by ORBi |
Lembreghts, M., & Ansseau, M. (1993). Les marqueurs biologiques dans les schizophrénies. Encéphale (L'), 19 (5, Sep-Oct), 501-23. Peer Reviewed verified by ORBi |
Ansseau, M., & De Roeck, J. (1993). Trazodone in Benzodiazepine Dependence. Journal of Clinical Psychiatry, 54 (5), 189-191. Peer Reviewed verified by ORBi |
ANSSEAU, M. (1993). The paradox of tianeptine. European Psychiatry, 8 (SUPPL. 2), 89s-93. Peer Reviewed verified by ORBi |
ANSSEAU, M., Troisfontaines, B., Papart, P., & von Frenckell, R. (1993). Compulsive personality and serotonergic drugs. European Neuropsychopharmacology, 3 (3), 288-289. doi:10.1016/0924-977X(93)90077-Y Peer Reviewed verified by ORBi |
ANSSEAU, M., Jammaer, R., Réel, C., Wauthy, J., Lembreghts, M., PITCHOT, W., Moreno, A. G., Sulon, J., & Legros, J.-J. (1993). Effect of pindolol on the neuroendocrine and temperature responses to flesinoxan. European Neuropsychopharmacology, 3 (3), 368. doi:10.1016/0924-977X(93)90154-E Peer Reviewed verified by ORBi |
Hansenne, M., Charles, G., Pholien, P., Panzer, M., PITCHOT, W., Gonzalez Moreno, A., & ANSSEAU, M. (1993). Mesure subjective de l'impact d'un évènement : Traduction française et validation de l'échelle d’Horowitz. Psychologie Médicale, 25 (1), 86-88. Peer reviewed |
Pitchot, W., Gonzalez Moreno, A., Hansenne, M., Wauthy, J., & Ansseau, M. (1993). Role du systeme dopaminergique dans la depression: correlats cliniques du test a l'apomorphine. Acta Psychiatrica Belgica, 93 Spec No, 343-358. Peer Reviewed verified by ORBi |
ANSSEAU, M., PITCHOT, W., Gonzalez Moreno, A., Papart, P., & WAUTHY, J. (1993). Pilot study of flesinoxan in major depression. Effect on REM latency and body temperature. Human Psychopharmacology, 8 (4), 279-283. doi:10.1002/hup.470080407 Peer Reviewed verified by ORBi |
ANSSEAU, M., PITCHOT, W., Papart, P., Gonzalez Moreno, A., Timsit-Berthier, M., & LEGROS, J.-J. (1993). Intérêt des marqueurs biologiques de dépression dans le choix du traitement antidépressif. Médecine et Hygiène, 51 (1990), 1970-1976. Peer Reviewed verified by ORBi |
Legros, J.-J., ANSSEAU, M., & Timsit-Berthier, M. (1993). Neurohypophyseal peptides and psychiatric diseases. Regulatory Peptides, 45 (1-2), 133-138. doi:10.1016/0167-0115(93)90195-E Peer Reviewed verified by ORBi |
PITCHOT, W., Ansseau, M., Réel, C., Gonzalez Moreno, A., Papart, P., & Hansenne, M. (1992). Red blood cell folate and suicidal behavior. European Neuropsychopharmacology, 2 (3), 306-307. doi:10.1016/0924-977X(92)90143-V Peer Reviewed verified by ORBi |
PITCHOT, W., Gonzalez Moreno, A., Ansseau, M., Hansenne, M., & Papart, P. (1992). Clonidine test in bipolar vs unipolar melancholic patients. European Neuropsychopharmacology, 2 (3), 306. doi:10.1016/0924-977X(92)90142-U Peer Reviewed verified by ORBi |
Legros, J.-J., & Ansseau, M. (1992). Neurohypophyseal Peptides and Psychopathology. Progress in Brain Research, 93, 455-460, discussion 461. doi:10.1016/S0079-6123(08)64589-6 Peer Reviewed verified by ORBi |
PITCHOT, W., Gonzalez Moreno, A., ANSSEAU, M., & von Frenckell, R. (1992). Relationship between clonidine test and suicidal behavior. European Neuropsychopharmacology, 2 (3), 307. doi:10.1016/0924-977X(92)90144-W Peer Reviewed verified by ORBi |
PITCHOT, W., Gonzalez Moreno, A., & ANSSEAU, M. (1992). Therapeutic window for 5-HT reuptake inhibitors. The Lancet, 339 (8794). doi:10.1016/0140-6736(92)90858-Z Peer Reviewed verified by ORBi |
Schittecatte, M., ANSSEAU, M., Charles, G., Machowski, R., Papart, P., PITCHOT, W., & Wilmotte, J. (1992). Growth hormone response to clonidine in male untreated panic patients. Psychological Medicine, 22 (4), 1059-1062. doi:10.1017/s0033291700038630 Peer Reviewed verified by ORBi |
Ansseau, M. (1992). Diagnostic and therapeutic usefulness of biological markers of depression [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/266202 |
Ansseau, M., Pitchot, W., Hansenne, M., & Gonzalez Moreno, A. (1992). Psychotic reactions to zolpidem. The Lancet, 339 (8796), 809. doi:10.1016/0140-6736(92)91935-2 Peer Reviewed verified by ORBi |
Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Hansenne, M., & Wauthy, J. (1992). Evaluation neuroendocrienne de la fonction catécholaminergique dans le comportement suicidaire. Psychologie Médicale, 24 (11), 1200-1204. Peer reviewed |
ANSSEAU, M., PAPART, P., PITCHOT, W., Timsit-Berthier, M., Legros, J.-J., & von Frenckell, R. (1992). Dexamethasone suppression test and prediction of treatment response to selective antidepressants. European Psychiatry, 7 (4), 191-194. Peer Reviewed verified by ORBi |
ANSSEAU, M. (1992). Blunting of clonidine-stimulated growth hormone release in mania [19] [letter to the editor]. American Journal of Psychiatry, 149 (4), 584. doi:10.1176/ajp.149.4.584a Peer Reviewed verified by ORBi |
ANSSEAU, M., & De Roeck, J. (1992). Trazodone in benzodiazepine dependence. European Neuropsychopharmacology, 2 (3), 382. doi:10.1016/0924-977X(92)90237-3 Peer Reviewed verified by ORBi |
PITCHOT, W., ANSSEAU, M., Gonzalez Moreno, A., Hansenne, M., & Wauthy, J. (1992). Evaluation neuroendocrinienne de la fonction catécholaminergique dans le comportement suicidaire. Psychologie Médicale, 24 (11), 1200-1204. Peer reviewed |
ANSSEAU, M., PITCHOT, W., Gonzalez-Moreno, A., Papart, P., Gerritsen van der Hoop, R., & Bradford, D. (1992). Flesinoxan, a 5-HT1A agonist, in major depression: Clinical efficacy and effects on rem latency and body temperature (open study). European Neuropsychopharmacology, 2 (3), 313. doi:10.1016/0924-977X(92)90153-Y Peer Reviewed verified by ORBi |
ANSSEAU, M., Poncelet, P.-F., & Schmitz, D. (1992). High dose triazolam and anterograde amnesia [letter to the editor]. BMJ: British Medical Journal, 304 (6835), 1178. doi:10.1136/bmj.304.6835.1178-b Peer Reviewed verified by ORBi |
Pitchot, W., Ansseau, M., Gonzalez Moreno, A., Hansenne, M., & von Frenckell, R. (1992). Dopaminergic function in panic disorder: comparison with major and minor depression. Biological Psychiatry, 32 (11), 1004-1011. doi:10.1016/0006-3223(92)90061-4 Peer Reviewed verified by ORBi |
Hansenne, M., PITCHOT, W., Gonzalez-Moreno, A., von Frenckell, R., & Ansseau, M. (1992). Clonidine test and MMPI scales in major depression : State or trait markers? European Psychiatry, 7 (3), 129-133. Peer Reviewed verified by ORBi |
ANSSEAU, M., Lembreghts, M., Jammaer, R., Réel, C., Wauthy, J., PITCHOT, W., Gonzalez, M. A., Sulon, J., Legros, J.-J., & Bradford, L. D. (1992). Neuroendocrine responses to intravenous flesinoxan as an index of serotonergic neurotransmission. European Neuropsychopharmacology, 2 (3), 376. doi:10.1016/0924-977X(92)90229-2 Peer Reviewed verified by ORBi |
PITCHOT, W., Gonzalez Moreno, A., ANSSEAU, M., & von Frenckell, R. (1992). Growth hormone response to apomorphine test in retarded vs agitated depressed patients. European Neuropsychopharmacology, 2 (3), 307-308. doi:10.1016/0924-977X(92)90145-X Peer Reviewed verified by ORBi |
Legros, J.-J., Geenen, V., Gazzotti, C., Timsit-Berthier, M., & ANSSEAU, M. (1992). Peptides neurohypophysaires et psychopathologie. Revue Française d'Endocrinologie Clinique, Nutrition, et Métabolisme, 33 (2), 115-120. Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1992). Suicidal behavior and growth hormone response to apomorphine test. Biological Psychiatry, 31 (12), 1213-1219. doi:10.1016/0006-3223(92)90340-6 Peer Reviewed verified by ORBi |
Ansseau, M., Pitchot, W., Papart, P., Gonzalez Moreno, A., Lembreghts, M., & Legros, J.-J. (1992). Neuroendocrine Factors in Affective Disorders. Clinical Neuropharmacology, 15 (Suppl 1 Pt A), 574A-575. doi:10.1097/00002826-199201001-00299 Peer Reviewed verified by ORBi |
Mesters, P., ANSSEAU, M., Brasseur, R., Bussios, G., Cosyns, P., Czarka, M., De Buck, R., De Frenne, A., Dierick, M., & Linkowski, P. (1992). An open multicentre study to evaluate the efficacy and tolerance of fluoxetine 20 mg in depressed ambulatory patients. Acta Psychiatrica Belgica, 92 (4), 232-245. Peer Reviewed verified by ORBi |
ANSSEAU, M., Caillé, P., Derks, C., Cieren-Puiseux, I., Wauthy, J., Ego, D., Curet, O., Thiola, A., Rovei, V., & Jarreau, F. X. (1992). Phase I study of single ascending doses of befloxatone, a new reversible MAO-A inhibitor antidepressant. European Neuropsychopharmacology, 2 (3), 300. doi:10.1016/0924-977x(92)90133-s Peer Reviewed verified by ORBi |
Legros, J.-J., Gazzotti, C., Carvelli, T., Franchimont, P., Timsit-Berthier, M., von Frenckell, R., & Ansseau, M. (1992). Apomorphine Stimulation of Vasopressin- and Oxytocin-Neurophysins. Evidence for Increased Oxytocinergic and Decreased Vasopressinergic Function in Schizophrenics. Psychoneuroendocrinology, 17 (6), 611-617. doi:10.1016/0306-4530(92)90019-4 Peer Reviewed verified by ORBi |
ANSSEAU, M., Cerfontaine, J.-L., Darimont, P., de Nayer, A. R., Devoitille, J.-M., Dierick, M., Evrard, J.-L., Gérard, M.-A., Kremer, P. J., Lecoq, A., Mertens, C., Mesotten, F., Troisfontaines, B., van Moffaert, M., & Vanbrabant, E. (1992). Nefazodone vs amitriptyline in major depressive inpatients. European Neuropsychopharmacology, 2 (3), 295. doi:10.1016/0924-977X(92)90128-U Peer Reviewed verified by ORBi |
WAUTHY, J., Ansseau, M., von Frenckell, R., Mormont, C., & Legros, J.-J. (01 October 1991). Memory disturbances and dexamethasone suppression test in major depression. Biological Psychiatry, 30 (7), 736-738. doi:10.1016/0006-3223(91)90020-M Peer Reviewed verified by ORBi |
Ansseau, M., Troisfontaines, B., Papart, P., & von Frenckell, R. (28 September 1991). Compulsive Personality as Predictor of Response to Serotoninergic Antidepressants. BMJ: British Medical Journal, 303 (6805), 760-1. doi:10.1136/bmj.303.6805.760 Peer Reviewed verified by ORBi |
Papart, P., ANSSEAU, M., & Timsit-Berthier, M. (1991). Contingent Negative Variation and response to antidepressants. European Neuropsychopharmacology, 1 (3), 461. doi:10.1016/0924-977X(91)90679-O Peer Reviewed verified by ORBi |
Ansseau, M., Devoitille, J.-M., Papart, P., Vanbrabant, E., Mantanus, H., & Timsit-Berthier, M. (1991). Comparison of Adinazolam, Amitriptyline, and Diazepam in Endogenous Depressive Inpatients Exhibiting Dst Nonsuppression or Abnormal Contingent Negative Variation. Journal of Clinical Psychopharmacology, 11 (3), 160-165. doi:10.1097/00004714-199106000-00003 Peer Reviewed verified by ORBi |
Piccinin, B., & Ansseau, M. (1991). Intérêt du sommeil et des tests neuroendocriniens en tant que marqueurs biologiques de la dépression chez l'enfant et l'adolescent. Encéphale (L'), 17 (5, Sep-Oct), 457-466. Peer Reviewed verified by ORBi |
Timsit-Berthier, M., Ansseau, M., Mantanus, H., Schoenen, J., & Legros, J.-J. (1991). Contingent negative variation in psychopharmacology. In C. H. M. Brunia, G. Mulder, ... M. N. Verbater (Eds.), Event related potentials in brain research (pp. 31-45). Amsterdam, Netherlands: Elsevier. |
ANSSEAU, M., von Frenckell, R., & Serre, C. (1991). Pilot study of milnacipran in panic disorder. European Psychiatry, 6 (2), 103-105. Peer Reviewed verified by ORBi |
Ansseau, M., Olie, J. P., von Frenckell, R., Jourdain, G., Stehle, B., & Guillet, P. (1991). Controlled Comparison of the Efficacy and Safety of Four Doses of Suriclone, Diazepam, and Placebo in Generalized Anxiety Disorder. Psychopharmacology, 104 (4), 439-443. doi:10.1007/BF02245646 Peer Reviewed verified by ORBi |
ANSSEAU, M., PITCHOT, W., Gonzalez Moreno, Hansenne, M., papart, P., Gerritsen Van Der Hoop, R., & Bradford, D. (1991). Pilot study of flesinoxan, a 5-HT1A agonist, in major depression. Biological Psychiatry. Peer Reviewed verified by ORBi |
PITCHOT, W., ANSSEAU, M., Gonzales Moreno, A., Papart, P., Gerritsen van der Hoop, R., & Bradford, D. (1991). Pilot study of flesinoxan, a 5-HT1A agonist, in major depression. European Neuropsychopharmacology, 1 (3), 436. doi:10.1016/0924-977x(91)90641-7 Peer Reviewed verified by ORBi |
PITCHOT, W., ANSSEAU, M., Gonzalez Moreno, A., Hansenne, M., & von Frenckell, R. (1991). Dopaminergic function in panic disorder. European Neuropsychopharmacology, 1 (3), 464. doi:10.1016/0924-977x(91)90685-n Peer Reviewed verified by ORBi |
Ansseau, M., & von Frenckell, R. (1991). Intérêt du prazepam gouttes dans le traitement bref des troubles anxieux. Encéphale (L'), 17 (4), 291-294. Peer Reviewed verified by ORBi |
PITCHOT, W., Hansenne, M., Gonzalez Moreno, A., & Ansseau, M. (1991). Suicidal behavior and growth hormone response to apomorphine test. European Neuropsychopharmacology, 1 (3), 462. doi:10.1016/0924-977x(91)90681-j Peer Reviewed verified by ORBi |
PITCHOT, W., Hansenne, M., Charles, G., Machowski, R., ANSSEAU, M., Gonzalez Moreno, A., Schittecatte, M., Wilmotte, J., & Mirel, J. (1991). P300 in posttraumatic stress disorder: preliminary results. European Neuropsychopharmacology, 1 (3), 465-466. doi:10.1016/0924-977X(91)90687-P Peer Reviewed verified by ORBi |
Hansenne, M., Pitchot, W., & Ansseau, M. (1991). The clonidine test in posttraumatic stress disorder. American Journal of Psychiatry, 148 (6), 810-811. doi:10.1176/ajp.148.6.810b Peer Reviewed verified by ORBi |
Pitchot, W., Hansenne, M., & Ansseau, M. (1991). The lack of relationship between DST nonsuppression in the dexamethasone suppression test and EEG abnormalities. European Archives of Psychiatry and Clinical Neuroscience, 241 (3), 193-4. doi:10.1007/BF02219721 Peer Reviewed verified by ORBi |
Ansseau, M., von Frenckell, R., Gérard, M.-A., Mertens, C., De Wilde, J., Botte, L., Devoitille, J. M., Evrard, J. L., De Nayer, A., & Orban, P. (1991). Interest of a Loading Dose of Milnacipran in Endogenous Depressive Inpatients. Comparison with the Standard Regimen and with Fluvoxamine. European Neuropsychopharmacology, 1 (2), 113-121. doi:10.1016/0924-977x(91)90712-4 Peer Reviewed verified by ORBi |
Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., & Papart, P. (1991). Pilot Study of Pk 11195, a Selective Ligand for the Peripheral-Type Benzodiazepine Binding Sites, in Inpatients with Anxious or Depressive Symptomatology. Pharmacopsychiatry, 24 (1), 8-12. doi:10.1055/s-2007-1014425 Peer Reviewed verified by ORBi |
Pitchot, W., Ansseau, M., & Franck, G. (December 1990). Aspects pratiques de l'utilisation des antidépresseurs. Revue Médicale de Liège, 45 (12), 597-613. Peer reviewed |
Pitchot, W., Hansenne, M., Moreno, A. G., von Frenckell, R., & Ansseau, M. (1990). Psychopathological correlates of dopaminergic disturbances in major depression. Neuropsychobiology, 24 (4), 169-72. doi:10.1159/000119481 Peer Reviewed verified by ORBi |
Ansseau, M., Papart, P., Gérard, M.-A., von Frenckell, R., & Franck, G. (1990). Controlled Comparison of Buspirone and Oxazepam in Generalized Anxiety. Neuropsychobiology, 24 (2), 74-78. doi:10.1159/000119464 Peer Reviewed verified by ORBi |
von Frenckell, R., Ansseau, M., Serre, C., & Sutet, P. (1990). Pooling Two Controlled Comparisons of Milnacipran (F2207) and Amitriptyline in Endogenous Inpatients. A New Approach in Dose Ranging Studies. International Clinical Psychopharmacology, 5 (1), 49-56. doi:10.1097/00004850-199001000-00005 Peer Reviewed verified by ORBi |
Papart, P., & ANSSEAU, M. (1990). Milnacipran in obsessive-compulsive disorder: Study in one case. Psychiatrie et Psychobiologie, 5 (5), 325-327. Peer Reviewed verified by ORBi |
Papart, P., & Ansseau, M. (1990). Milnacipran et trouble obsessionnel-compulsif: étude d'un cas. Psychiatrie et Psychobiologie, 5 (5), 325-327. Peer Reviewed verified by ORBi |
von Frenckell, R., ANSSEAU, M., Dulcire, C., & Waintraub, L. (1990). Effects of tianeptine on vigilance and memory in young healthy volunteers. Psychiatrie et Psychobiologie, 5 (6), 375-380. doi:10.1177/0269881115573810 Peer Reviewed verified by ORBi |
Papart, P., Ansseau, M., Devoitille, J. M., Mantanus, H., & Timsit-Berthier, M. (1990). Contingent negative variation and severity of depression. In Psychiatry: A world perspective - Volume 2 (pp. 402-408). Elsevier Science Publishers. Peer reviewed |
PITCHOT, W., & Ansseau, M. (1990). Aspects pratique de l'utilisation des antidépresseurs. Revue Médicale de Liège, 45 (12), 597-613. Peer reviewed |
Charles, G., & ANSSEAU, M. (1990). Les critères de diagnostic pour la recherche en psychatrie (RDC) et le guide pour le diagnostic des troubles affectifs et de la schizophrénie (SADS). Acta Psychiatrica Belgica, 90 (5-6), 225-238. Peer Reviewed verified by ORBi |
Ansseau, M., & von Frenckell, R. (1990). Controlled Comparison of Two Anxiolytic Benzodiazepines, Cloxazolam and Bromazepam. Neuropsychobiology, 24 (1), 25-29. doi:10.1159/000119038 Peer Reviewed verified by ORBi |
ANSSEAU, M. (1989). Les relations anxiété-sommeil et leur incidence en pharmacologie clinique. Psychologie Médicale, 21 (6), 765-773. Peer reviewed |
Machowski, R., ANSSEAU, M., Charles, G., Schittecatte, M., & Wilmotte, J. (1989). Latencies of rem sleep and awakening in major depression: Possible indicators of cholinergic activity. Neurophysiologie Clinique, 19 (5), 385-391. doi:10.1016/S0987-7053(89)80091-7 Peer Reviewed verified by ORBi |
Legros, J.-J., & Ansseau, M. (1989). Increased Basal Plasma Vasopressin-Neurophysin in Mania. Hormone Research, 31 (1-2), 55-58. doi:10.1159/000181087 Peer Reviewed verified by ORBi |
PITCHOT, W., ANSSEAU, M., PAPART, P., Franck, G., & Rorive, G. (1989). Hyponatrémie induite par la carbamazépine et affection rénale : à propos d'un cas. Psychiatrie et Psychobiologie, 4 (4), 235-237. doi:10.1017/S0767399X00002807 Peer Reviewed verified by ORBi |
Ansseau, M., von Frenckell, R., Mertens, C., de Wilde, J., Botte, L., Devoitille, J. M., Evrard, J. L., De Nayer, A., Orban, P., & Dejaiffe, G. (1989). Controlled Comparison of Two Doses of Milnacipran (F 2207) and Amitriptyline in Major Depressive Inpatients. Psychopharmacology, 98 (2), 163-8. doi:10.1007/BF00444686 Peer Reviewed verified by ORBi |
Couvreur, V., Ansseau, M., & Franck, G. (1989). L'électroconvulsivothérapie et ses mécanismes d'actions. Acta Psychiatrica Belgica, 89 (1-2, Jan-Apr), 96-109. Peer Reviewed verified by ORBi |
ANSSEAU, M., von Frenckell, R., Papart, P., Mertens, C., De Wilde, J., Botte, L., Devoitille, J.-M., Evrard, J. L., De Nayer, A., Koch‐Bourdouxhe, S., Darimont, P., Lecoq, A., Mirel, J., Couzinier, J. P., Demarez, J. P., & Serre, C. (1989). Controlled comparison of milnacipran (F2207) 200 mg and amitriptyline in endogenous depressive inpatients. Human Psychopharmacology, 4 (3), 221-227. doi:10.1002/hup.470040308 Peer Reviewed verified by ORBi |
ANSSEAU, M. (1988). Les antidépresseurs. Médecine et Hygiène, 46 (1759), 2314-2321. Peer Reviewed verified by ORBi |
Mantanus, H., Ansseau, M., Legros, J.-J., & Timsit-Berthier, M. (1988). Relation entre le test de suppression à la dexaméthasone et la variation contingente négative chez des patients déprimés majeurs. Neurophysiologie Clinique, 18 (4), 345-353. doi:10.1016/s0987-7053(88)80091-1 Peer Reviewed verified by ORBi |
Geenen, V., Adam, F., Baro, V., Mantanus, H., Ansseau, M., Timsit-Berthier, M., & Legros, J.-J. (1988). Inhibitory influence of oxytocin infusion on contingent negative variation and some memory tasks in normal men. Psychoneuroendocrinology, 13 (5), 367-375. doi:10.1016/0306-4530(88)90043-1 Peer Reviewed verified by ORBi |
ANSSEAU, M. (1988). Le traitement pharmacologique de l'anxiété. Revue Médicale de Liège, 43 (3), 80-91. Peer reviewed |
ANSSEAU, M., & Franck, G. (1988). Vers une méthodologie objective en psychopathologie: l'apport des nouveaux systèmes diagnostiques de la psychométrie et de la psychiatrie biologique. Acta Medicinae Legalis et Socialis, 38 (2), 151-167. Peer Reviewed verified by ORBi |
Ansseau, M., Bataille, M., Bobon, D., Cerfontaine, J.-L., Charles, G., Couteaux, F., Diricq, S., Fraipont, J., Gernay, P., & Troisfontaines, B. (1988). Evaluation de l'activité clinique de la fluoxetine (Prozac) selon "les étoiles de Liège". Acta Psychiatrica Belgica, 88 (2), 127-37. Peer Reviewed verified by ORBi |
Jacqmin, P., & ANSSEAU, M. (1988). Comparison of sublingual and oral prazepam in normal subjects. II. Pharmacokinetic and pharmacodynamic data. Neuropsychobiology, 19 (4), 186-191. doi:10.1159/000118458 Peer Reviewed verified by ORBi |
ANSSEAU, M., von Frenckell, R., & Legros, J.-J. (1988). Reply to Swartz [letter to the editor]. Psychiatry Research, 24 (3), 361. doi:10.1016/0165-1781(88)90116-3 Peer Reviewed verified by ORBi |
Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1988). Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. British Journal of Psychiatry, 153 (1), 65-71. doi:10.1192/bjp.153.1.65 Peer Reviewed verified by ORBi |
Ansseau, M., von Frenckell, R., Franck, G., Reynolds, C. F., & Kupfer, D. J. (December 1987). Sommeil et dépression: vers une standardisation de l'utilisation de la latence du sommeil paradoxal en tant que marqueur biologique de dépression majeure. Revue d'Électroencephalographie et de Neurophysiologie Clinique, 17 (4), 411-24. doi:10.1016/S0370-4475(87)80087-4 Peer Reviewed verified by ORBi |
Ansseau, M., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1987). Neuroendocrine evaluation of catecholaminergic neurotransmission in mania. Psychiatry Research, 22 (3), 193-206. doi:10.1016/0165-1781(87)90034-5 Peer Reviewed verified by ORBi |
Papart, P., & Ansseau, M. (1987). Echelle manie-depression de l'AMDP et inversion maniaque. Psychiatrie et Psychobiologie, II (3). Peer Reviewed verified by ORBi |
Timsit-Berthier, M., Mantanus, H., Ansseau, M., Devoitille, J. M., Dal Mas, A., & Legros, J.-J. (1987). Contingent Negative Variation in Major Depressive Patients. Electroencephalography and Clinical Neurophysiology. Supplement, 40, 762-771. Peer Reviewed verified by ORBi |
D'haenen, H., de Weert, D., & ANSSEAU, M. (1987). Lack of effects of hospitalization and oral contraceptives on DST results in control subjects. Biological Psychiatry, 22 (12), 1499-1502. doi:10.1016/0006-3223(87)90113-2 Peer Reviewed verified by ORBi |
Ansseau, M., von Frenckell, R., & Jacqmin, P. (1987). Comparison of Sublingual and Oral Prazepam in Normal Subjects. I. Clinical Data. Neuropsychobiology, 18 (2), 77-82. doi:10.1159/000118397 Peer Reviewed verified by ORBi |
Legros, J.-J., Geenen, V., & Ansseau, M. (1987). Le point actuel sur l'utilisation de la vasopressine et de l'ocytocine en psychiatrie. Médecine et Hygiène, 45, 2169-2177. Peer Reviewed verified by ORBi |
Ansseau, M., Legros, J.-J., Mormont, C., Cerfontaine, J.-L., Papart, P., Geenen, V., & Franck, G. (1987). Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology, 12, 231-236. doi:10.1016/0306-4530(87)90009-6 Peer Reviewed verified by ORBi |
ANSSEAU, M., Cerfontaine, J.-L., von Frenckell, R., Charles, G., Papart, P., & Franck, G. (1987). L'index de Newcastle pour le diagnostic de dépression endogène : Comparaison avec les critères de diagnostic pour la recherche de dépression majeure. Encéphale (L'), 13 (2), 67-72. Peer Reviewed verified by ORBi |
ANSSEAU, M., Depauw, Y., Charles, G., Castro, P., D'Haenen, H., De Vigne, J.-P., Hubain, P., Legros, J.-J., Pelc, I., Toscano, A., Wilmotte, J., & Mendlewicz, J. (1987). Age and gender effects on the diagnostic power of the DST. Journal of Affective Disorders, 12 (3), 185-191. doi:10.1016/0165-0327(87)90025-5 Peer Reviewed verified by ORBi |
Demey-Ponsart, E., Ansseau, M., Sulon, J., von Frenckell, R., Cerfontaine, J.-L., Papart, P., Franck, G., Geenen, V., & Legros, J.-J. (1987). Diagnostic performance of basal free cortisol/18-hydroxy-11-deoxy-corticosterone (18-OH-DOC) ratio in endogenous depression: comparison with the dexamethasone suppression test. Biological Psychiatry, 22 (8), 947-956. doi:10.1016/0006-3223(87)90004-7 Peer Reviewed verified by ORBi |
ANSSEAU, M. (1987). Troubles du sommeil et affections psychiatriques. Revue Médicale de Liège, 42 (20), 826-831. Peer reviewed |
Papart, P., Ansseau, M., Cerfontaine, J.-L., & Franck, G. (May 1986). Adinazolam-Induced Mania. American Journal of Psychiatry, 143 (5), 684-685. doi:10.1176/ajp.143.5.684-a Peer Reviewed verified by ORBi |
Ansseau, M., von Frenckell, R., Franck, G., Timsit-Berthier, M., Geenen, V., & Legros, J.-J. (1986). Blunted growth hormone response to clonidine and apomorphine challenges in endogenous depression. In C. Shagass (Ed.), Biological psychiatry : proceedings of the IVth world congress of biological psychiatry, September 8th through 13th, 1985 in Philadelphia (pp. 793-795). New York, United States: Elsevier. |
Timsit-Berthier, M., Mantanus, H., Marissiaux, P., Ansseau, M., Doumont, A., Geenen, V., & Legros, J.-J. (1986). CNV and dopamine receptor reactivity: correlations with the apomorphine test. In W. C. McCallum (Ed.), Cerebral psychophysiology: Studies in event-related potentials (pp. 403-405). New York, United States: Elsevier. |
Ansseau, M., Geenen, V., Franck, G., & Legros, J.-J. (1986). Dexamethasone suppression test and MMPI scales. Neuropsychobiology, 16 (2-3), 68-71. doi:10.1159/000118300 Peer Reviewed verified by ORBi |
von Frenckell, R., ANSSEAU, M., & Bonnet, D. (1986). Evaluation of the sedative properties of PK 8165 (Pipequaline), a benzodiazepine partial agonist, in normal subjects. International Clinical Psychopharmacology, 1 (1), 24-35. doi:10.1097/00004850-198601000-00004 Peer Reviewed verified by ORBi |
Charles, G., ANSSEAU, M., Sulon, J., Demey-ponsart, E., Meunier, J.-C., Wilmotte, J., & Jean-jacques, L. (1986). Free cortisol and the dexamethasone suppression test. Biological Psychiatry, 21 (5-6), 549-552. doi:10.1016/0006-3223(86)90199-X Peer Reviewed verified by ORBi |
ANSSEAU, M. (1986). Les troubles anxieux : Diagnostic et traitement. Médecine et Hygiène, 44 (1666), 2090-2094. Peer Reviewed verified by ORBi |
Legros, J.-J., & ANSSEAU, M. (1986). Vasopressin-neurophysin and bipolar depression. Biological Psychiatry, 21 (12), 1212-1216. doi:10.1016/0006-3223(86)90226-X Peer Reviewed verified by ORBi |
ANSSEAU, M. (1986). Les marqueurs biologiques de la dépression. Revue Médicale de Liège, 41 (9), 349-360. Peer reviewed |
ANSSEAU, M., von Frenckell, R., Simon, C., Sulon, J., Demey-Ponsart, E., & Franck, G. (1986). Prediction of cortisol response to dexamethasone from age and basal cortisol in normal volunteers: A negative study. Psychopharmacology, 90 (2), 276-277. doi:10.1007/BF00181258 Peer Reviewed verified by ORBi |
ANSSEAU, M., Reynolds III., C. F., Kupfer, D. J., Poncelet, P.-F., Franck, G., Dresse, A., & Reznik, M. (1986). Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 47 (6), 320-321. Peer Reviewed verified by ORBi |
Ansseau, M., De Schepper, P., D'Haene, H., Dresse, A., Godderis, I., Harvengt, C., Herman, A., & Pelc, I. (21 October 1985). Les benzodiazépines dans le traitement de l'anxiété diurne : aspects pharmacologiques, la question de la dépendance, aspects cliniques [Paper presentation]. Retranscription intégrale de la table ronde qui s'est tenue au château de la Hulpe le 21 octobre 1985. |
ANSSEAU, M., Kupfer, D. J., Reynolds III, C. F., & Coble, P. A. (1985). "Paradoxical" shortening of REM latency on first recording night in major depressive disorder: Clinical and polysomnographic correlates. Biological Psychiatry, 20 (2), 135-145. doi:10.1016/0006-3223(85)90073-3 Peer Reviewed verified by ORBi |
ANSSEAU, M., Doumont, A., Thiry, D., von Frenckell, R., & Collard, J. (1985). Initial study of methylclonazepam in generalized anxiety disorder - Evidence for greater power in the cross-over design. Psychopharmacology, 87 (2), 130-135. doi:10.1007/BF00431795 Peer Reviewed verified by ORBi |
Ansseau, M. (1985). Intérêt de la latence du sommeil paradoxal en tant que marqueur biologique des états dépressifs : Comparaison avec trois tests neuroendocriniens [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/266411 |
ANSSEAU, M., Diricq, S., & Bataille, M. (1985). Une physionomie comparée originale de l'activité clinique des antidépresseurs. Acta Psychiatrica Belgica, 85 (5), 644-661. Peer Reviewed verified by ORBi |
ANSSEAU, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Demonceau, G., Legros, J.-J., & Franck, G. (1985). Intérêt de l'EEG de sommeil en tant que marqueur biologique des états dépressifs. Comparaison avec trois tests neuro-endocriniens. Revue d'Électroencephalographie et de Neurophysiologie Clinique, 14 (4), 343-349. doi:10.1016/S0370-4475(85)80059-9 Peer Reviewed verified by ORBi |
Ansseau, M., Reynolds, C. F. I., Kupfer, D., Doumont, A., Geenen, V., Dresse, A., & Juorio, A. (1985). Extrapyramidal signs following zimelidine overdose. Journal of Clinical Psychopharmacology, 5 (6), 347-348. doi:10.1097/00004714-198512000-00010 Peer Reviewed verified by ORBi |
Geenen, V., Langer, G., Koïnig, G., Schönbeck, G., Ansseau, M., von Frenckell, R., & Legros, J.-J. (1985). Release of human neurophysin I during insulin-induced hypoglycemia is abolished after recovery with clomipramine treatment. Psychoneuroendocrinology, 10 (1), 61-69. doi:10.1016/0306-4530(85)90039-3 Peer Reviewed verified by ORBi |
ANSSEAU, M., Kupfer, D. J., & Reynolds, C. F. (1985). Internight variability of REM latency in major depression: Implications for the use of REM latency as a biological correlate. Biological Psychiatry, 20 (5), 489-505. doi:10.1016/0006-3223(85)90021-6 Peer Reviewed verified by ORBi |
Ansseau, M., Doumont, A., Cerfontaine, J.-L., Sulon, J., Demey-Ponsart, E., Geenen, V., & Legros, J.-J. (1985). Diagnostic performance of the thirty-four hour dexamethasone suppression test. Psychoneuroendocrinology, 10, 215-219. doi:10.1016/0306-4530(85)90060-5 Peer Reviewed verified by ORBi |
Brasseur, R., van Moffaert, M., Mesotten, F., ANSSEAU, M., Uytdenhoef, P., & Bartholome, F. (1985). A Belgian multicentre study of fluvoxamine in depressive outpatients. Acta Psychiatrica Belgica, 85 (5), 636-643. Peer Reviewed verified by ORBi |
ANSSEAU, M. (1985). BENZODIAZEPINES ET SOMMEIL. Acta Psychiatrica Belgica, 85 (4), 522-532. Peer Reviewed verified by ORBi |
ANSSEAU, M., Machowski, R., Franck, G., & Timsit-Berthier, M. (1985). REM sleep latency and contingent negative variation in endogenous depression suggestion for a common cholinergic mechanism. Biological Psychiatry, 20 (12), 1303-1307. doi:10.1016/0006-3223(85)90115-5 Peer Reviewed verified by ORBi |
ANSSEAU, M., Ansoms, C., Beckers, G., Bogaerts, M., Botte, L., De Buck, R., Diricq, S., Dumortier, A., Jansegers, E., Owieczka, J., & Stellamans, G. (1984). Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression. Journal of Affective Disorders, 7 (3-4), 287-296. doi:10.1016/0165-0327(84)90050-8 Peer Reviewed verified by ORBi |
ANSSEAU, M., Doumont, A., Cerfontaine, J.-L., Mantanus, H., Rousseau, J.-C., & Timsit-Berthier, M. (1984). Self-reports of anxiety level and EEG changes after a single dose of benzodiazepines: Double-blind comparison of two forms of oxazepam. Neuropsychobiology, 12 (4), 255-259. doi:10.1159/000118148 Peer Reviewed verified by ORBi |
ANSSEAU, M., Thiry, D., & Doumont, A. (1984). Klinische studie van Lormetazepam 2mg bij slaapstoornissen van gehospitaliseerde psychiatrische patiënten. Ars medici: Internationaal tijdschrift voor praktische therapie, 39 (1), 46-51. Peer reviewed |
ANSSEAU, M., Doumont, A., von Frenckell, R., & Collard, J. (1984). A long-acting benzodiazepine is more effective in divided doses [letter to the editor]. New England Journal of Medicine, 310 (8), 526. doi:10.1056/NEJM198402233100813 Peer Reviewed verified by ORBi |
ANSSEAU, M., Doumont, A., von Frenckell, R., & Collard, J. (1984). Duration of benzodiazepine clinical activity: Lack of direct relationship with plasma half-life - A comparison of single vs divided dosage schedules of prazepam. Psychopharmacology, 84 (3), 293-298. doi:10.1007/BF00555201 Peer Reviewed verified by ORBi |
ANSSEAU, M., Doumont, A., & Diricq, S. (1984). Methodology required to show clinical differences between benzodiazepines. Current Medical Research and Opinion, 8 (s4), 108-114. doi:10.1185/03007998409109548 Peer Reviewed verified by ORBi |
ANSSEAU, M., Kupfer, D. J., Reynolds III, C. F., & McEachran, A. B. (1984). REM latency distribution in major depression: Clinical characteristics associated with sleep onset REM periods. Biological Psychiatry, 19 (12), 1651-1666. Peer Reviewed verified by ORBi |
ANSSEAU, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Legros, J.-J., & Franck, G. (1984). Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: A pilot study. Psychiatry Research, 12 (3), 261-272. doi:10.1016/0165-1781(84)90031-3 Peer Reviewed verified by ORBi |
ANSSEAU, M., Sulon, J., Doumont, A., Cerfontaine, J.-L., Legros, J.-J., Sodoyez, J.-C., & Demey-Ponsart, E. (1984). Use of saliva cortisol in the dexamethasone suppression test. Psychiatry Research, 13 (3), 203-211. doi:10.1016/0165-1781(84)90035-0 Peer Reviewed verified by ORBi |
ANSSEAU, M., & Diricq, S. (1983). Lormetazepam and amobarbital sodium in the outpatient treatment of insomnia: A controlled trial. Clinical Therapeutics, 5 (4), 365-376. Peer Reviewed verified by ORBi |
Ansseau, M., Doumont, A., Thiry, D., Geenen, V., & Legros, J.-J. (1983). Interest of 5-hydroxytryptophan (5-HTP) test as a neuroendocrine marker of depressive illness. Acta Psychiatrica Belgica, 83 (1), 50-56. Peer Reviewed verified by ORBi |
ANSSEAU, M. (1983). Comparaison de l'effet anxiolytique du prazepam selon deux schemas d'administration. Ars Medici, 38 (4), 267-277. |
ANSSEAU, M., Doumont, A., Thiry, D., & Gelders, Y. (1983). Pilot study of a specific serotonergic antagonist, pirenperone, in the treatment of anxiety disorders. Acta Psychiatrica Belgica, 83 (5), 517-524. Peer Reviewed verified by ORBi |
Legros, J.-J., Ansseau, M., Doumont, A., Geenen, V., & van Wimersma-Greidanus, T. (1983). Relationship between vasopressin, neurophysin and ACTH, cortisol plasma levels in non suppressor patients during dexamethasone suppression tests. Neuro Endocrinology Letters, 5 (5), 297-302. Peer Reviewed verified by ORBi |
ANSSEAU, M., Thiry, D., & Doumont, A. (1983). Etude clinique du lormetazepam 2mg dans l'insomnie des patients psychiatriques hospitalisés. Ars Medici, 38 (17-18), 1131-1145. Peer reviewed |
ANSSEAU, M., Dawson, A. F., & Champion, F. (1982). The use of high dose lormetazepam in psychiatric in-patients. Current Medical Research and Opinion, 7 (9), 598-600. doi:10.1185/03007998209110103 Peer Reviewed verified by ORBi |
ANSSEAU, M. (1982). De benzodiazepinen: van farmacologie tot kliniek Een praktische benadering. Ars Medici, 11 (5), 389-405. |
Bobon, D., Mormont, C., Doumont, A., Mirel, J., Bonhomme, P., Ansseau, M., Pellet, J., Pull, C., de Buck, R., Gernay, P., Mormont, I., Lang, F., Lejeune, J., Bronckart, C., & von Frenckell, R. (1982). Analyse factorielle de la révision française de l'échelle A.M.D.P. : résultats d'une étude internationale de 388 cas. Acta Psychiatrica Belgica, 82 (4), 371-389. Peer Reviewed verified by ORBi |
ANSSEAU, M., Doumont, A., & Cerfontaine, J.-L. (1982). De la necessite du diagnostic standardise dans la recherche en psychiatrie biologique. Essai d'integration des 'research diagnostic criteria' dans le systeme AMDP. Acta Psychiatrica Belgica, 82 (4), 422-440. Peer Reviewed verified by ORBi |
ANSSEAU, M. (1982). Les benzodiazépines : de la pharmacologie à la clinique, une approche pratique. Ars Medici, 37 (4), 241-257. |
ANSSEAU, M. (1981). Biological rhythms and behavior. Neuropsychobiology, 7 (5), 280. doi:10.1159/000117859 Peer Reviewed verified by ORBi |
Collard, J., & ANSSEAU, M. (1981). A research network of walloon psychiatrists working both on in- and out-patients for specialists and general practitioners. Advances in the Biosciences, 31 (C), 119-124. Peer reviewed |
ANSSEAU, M., Diricq, S., Grisar, T., & Collard, J. (1981). The malignant syndrome of neuroleptics: neuroendocrine and biochemical approaches. Neuroendocrinology Letters, 3 (2), 124. Peer reviewed |
ANSSEAU, M., & Diricq, S. (1981). Lormetazepam et amobarbital dans le traitement ambulatoire de l'insomnie : Une étude contrôlée. Acta Psychiatrica Belgica, 81 (6), 580-594. Peer Reviewed verified by ORBi |
ANSSEAU, M., Diricq, S., Grisar, T., & Collard, J. (1980). Biochemical and neuroendocrine approaches to a malignant syndrome of neuroleptics. Acta Psychiatrica Belgica, 80 (5), 600-606. Peer Reviewed verified by ORBi |
Collard, J., Diricq, S., & ANSSEAU, M. (1979). A comparative controlled clinical study of butriptyline (Evadyne), in standard and sustained-release formulations, in the treatment of depression. Pharmatherapeutica, 2 (4), 260-264. Peer Reviewed verified by ORBi |